Immunizing agent containing IMMUNOGLOBULIN G anti-Rho(D) used for preventing Rh immunization in Rh-negative individuals exposed to Rh-positive red blood cells.
Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA.
Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses.
All blood proteins except albumin ( = SERUM ALBUMIN, which is not a globulin) and FIBRINOGEN (which is not in the serum). The serum globulins are subdivided into ALPHA-GLOBULINS; BETA-GLOBULINS; and GAMMA-GLOBULINS on the basis of their electrophoretic mobilities. (From Dorland, 28th ed)
Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER).
A glycoprotein migrating as a beta-globulin. Its molecular weight, 52,000 or 95,000-115,000, indicates that it exists as a dimer. The protein binds testosterone, dihydrotestosterone, and estradiol in the plasma. Sex hormone-binding protein has the same amino acid sequence as ANDROGEN-BINDING PROTEIN. They differ by their sites of synthesis and post-translational oligosaccharide modifications.
Serum globulins that migrate to the gamma region (most positively charged) upon ELECTROPHORESIS. At one time, gamma-globulins came to be used as a synonym for immunoglobulins since most immunoglobulins are gamma globulins and conversely most gamma globulins are immunoglobulins. But since some immunoglobulins exhibit an alpha or beta electrophoretic mobility, that usage is in decline.
A large family of MONOMERIC GTP-BINDING PROTEINS that are involved in regulation of actin organization, gene expression and cell cycle progression. This enzyme was formerly listed as EC 3.6.1.47.
Erythrocyte isoantigens of the Rh (Rhesus) blood group system, the most complex of all human blood groups. The major antigen Rh or D is the most common cause of erythroblastosis fetalis.
A strain of HEPATITIS A VIRUS which causes hepatitis in humans. The virus replicates in hepatocytes and is presumed to reach the intestine via the bile duct. Transmission occurs by the fecal-oral route.
The body's defense mechanism against foreign organisms or substances and deviant native cells. It includes the humoral immune response and the cell-mediated response and consists of a complex of interrelated cellular, molecular, and genetic components.
A protein which effects termination of RNA synthesis during the genetic transcription process by dissociating the ternary transcription complex RNA;-RNA POLYMERASE DNA at the termination of a gene.
A disease caused by potent protein NEUROTOXINS produced by CLOSTRIDIUM BOTULINUM which interfere with the presynaptic release of ACETYLCHOLINE at the NEUROMUSCULAR JUNCTION. Clinical features include abdominal pain, vomiting, acute PARALYSIS (including respiratory paralysis), blurred vision, and DIPLOPIA. Botulism may be classified into several subtypes (e.g., food-borne, infant, wound, and others). (From Adams et al., Principles of Neurology, 6th ed, p1208)
The cutaneous and occasional systemic reactions associated with vaccination using smallpox (variola) vaccine.
Acute VIRAL CNS INFECTION affecting mammals, including humans. It is caused by RABIES VIRUS and usually spread by contamination with virus-laden saliva of bites inflicted by rabid animals. Important animal vectors include the dog, cat, bat, fox, raccoon, skunk, and wolf.
The presence of free HEMOGLOBIN in the URINE, indicating hemolysis of ERYTHROCYTES within the vascular system. After saturating the hemoglobin-binding proteins (HAPTOGLOBINS), free hemoglobin begins to appear in the urine.
A condition characterized by persistent spasms (SPASM) involving multiple muscles, primarily in the lower limbs and trunk. The illness tends to occur in the fourth to sixth decade of life, presenting with intermittent spasms that become continuous. Minor sensory stimuli, such as noise and light touch, precipitate severe spasms. Spasms do not occur during sleep and only rarely involve cranial muscles. Respiration may become impaired in advanced cases. (Adams et al., Principles of Neurology, 6th ed, p1492; Neurology 1998 Jul;51(1):85-93)
Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis.
Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.
A condition characterized by the abnormal presence of ERYTHROBLASTS in the circulation of the FETUS or NEWBORNS. It is a disorder due to BLOOD GROUP INCOMPATIBILITY, such as the maternal alloimmunization by fetal antigen RH FACTORS leading to HEMOLYSIS of ERYTHROCYTES, hemolytic anemia (ANEMIA, HEMOLYTIC), general edema (HYDROPS FETALIS), and SEVERE JAUNDICE IN NEWBORN.
A live VACCINIA VIRUS vaccine of calf lymph or chick embryo origin, used for immunization against smallpox. It is now recommended only for laboratory workers exposed to smallpox virus. Certain countries continue to vaccinate those in the military service. Complications that result from smallpox vaccination include vaccinia, secondary bacterial infections, and encephalomyelitis. (Dorland, 28th ed)
Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions.
Serum containing GAMMA-GLOBULINS which are antibodies for lymphocyte ANTIGENS. It is used both as a test for HISTOCOMPATIBILITY and therapeutically in TRANSPLANTATION.
Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen.
Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION.
INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.
INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water.
A serpin family member that binds to and transports GLUCOCORTICOIDS in the BLOOD.
An immunologic deficiency state characterized by an extremely low level of generally all classes of gamma-globulin in the blood.
Biologically active substances whose activities affect or play a role in the functioning of the immune system.
The administration of liquid medication or nutrients under the skin, usually over minutes or hours.
Blood proteins that bind to THYROID HORMONES such as THYROXINE and transport them throughout the circulatory system.
The type species of LYSSAVIRUS causing rabies in humans and other animals. Transmission is mostly by animal bites through saliva. The virus is neurotropic multiplying in neurons and myotubes of vertebrates.
A reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat HIV disease.
Immunoglobulins produced in response to VIRAL ANTIGENS.
Vaccines or candidate vaccines used to prevent infection with hepatitis A virus (HEPATOVIRUS).
The prevention of infection or disease following exposure to a pathogen.
The transference of a part of or an entire liver from one human or animal to another.
Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it.
The presence of organisms, or any foreign material that makes a drug preparation impure.
The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc.
A thyroid hormone transport protein found in serum. It binds about 75% of circulating THYROXINE and 70% of circulating TRIIODOTHYRONINE.
The process by which fetal Rh+ erythrocytes enter the circulation of an Rh- mother, causing her to produce IMMUNOGLOBULIN G antibodies, which can cross the placenta and destroy the erythrocytes of Rh+ fetuses. Rh isoimmunization can also be caused by BLOOD TRANSFUSION with mismatched blood.
Any vaccine raised against any virus or viral derivative that causes hepatitis.
Infections by bacteria, general or unspecified.
Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.
Diseases characterized by injury or dysfunction involving multiple peripheral nerves and nerve roots. The process may primarily affect myelin or nerve axons. Two of the more common demyelinating forms are acute inflammatory polyradiculopathy (GUILLAIN-BARRE SYNDROME) and POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING. Polyradiculoneuritis refers to inflammation of multiple peripheral nerves and spinal nerve roots.
An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities.
Therapy with two or more separate preparations given for a combined effect.
The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50).
An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.
Antibodies from an individual that react with ISOANTIGENS of another individual of the same species.
The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it.
The type species of ORTHOPOXVIRUS, related to COWPOX VIRUS, but whose true origin is unknown. It has been used as a live vaccine against SMALLPOX. It is also used as a vector for inserting foreign DNA into animals. Rabbitpox virus is a subspecies of VACCINIA VIRUS.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
The return of a sign, symptom, or disease after a remission.
An infant during the first month after birth.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis.
A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.
Serum proteins that have the most rapid migration during ELECTROPHORESIS. This subgroup of globulins is divided into faster and slower alpha(1)- and alpha(2)-globulins.
The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS.
Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen.
One or more types of plant seed proteins providing the large amounts of AMINO ACIDS utilized in GERMINATION and SEEDLING growth. As seeds are the major food source from AGRICULTURAL CROPS, seed storage proteins are a major source of DIETARY PROTEINS.
A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating AIDS-related complex (ARC) from AIDS include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in AIDS; follicular or mixed hyperplasia in ARC lymph nodes, leading to lymphocyte degeneration and depletion more typical of AIDS; evolving succession of histopathological lesions such as localization of Kaposi's sarcoma, signaling the transition to the full-blown AIDS.
A group of viruses in the PNEUMOVIRUS genus causing respiratory infections in various mammals. Humans and cattle are most affected but infections in goats and sheep have also been reported.
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES.
Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
A group of intracellular-signaling serine threonine kinases that bind to RHO GTP-BINDING PROTEINS. They were originally found to mediate the effects of rhoA GTP-BINDING PROTEIN on the formation of STRESS FIBERS and FOCAL ADHESIONS. Rho-associated kinases have specificity for a variety of substrates including MYOSIN-LIGHT-CHAIN PHOSPHATASE and LIM KINASES.
Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.
Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults.
Elements of limited time intervals, contributing to particular results or situations.
The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS.
The common chimpanzee, a species of the genus Pan, family HOMINIDAE. It lives in Africa, primarily in the tropical rainforests. There are a number of recognized subspecies.
Carbon-containing phosphonic acid compounds. Included under this heading are compounds that have carbon bound to either OXYGEN atom or the PHOSPHOROUS atom of the (P=O)O2 structure.
Methods used by pathogenic organisms to evade a host's immune system.
Freedom from exposure to danger and protection from the occurrence or risk of injury or loss. It suggests optimal precautions in the workplace, on the street, in the home, etc., and includes personal safety as well as the safety of property.
The species Oryctolagus cuniculus, in the family Leporidae, order LAGOMORPHA. Rabbits are born in burrows, furless, and with eyes and ears closed. In contrast with HARES, rabbits have 22 chromosome pairs.
Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced.
Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.
Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role.
Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.
A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases.
Serum proteins with an electrophoretic mobility that falls between ALPHA-GLOBULINS and GAMMA-GLOBULINS.
An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances.
A RHO GTP-BINDING PROTEIN involved in regulating signal transduction pathways that control assembly of focal adhesions and actin stress fibers. This enzyme was formerly listed as EC 3.6.1.47.
Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens.
Antibodies produced by a single clone of cells.
Electrophoresis applied to BLOOD PROTEINS.
The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host.
Injections made into a vein for therapeutic or experimental purposes.
An encapsulated lymphatic organ through which venous blood filters.
Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner.
Group of diseases mediated by the deposition of large soluble complexes of antigen and antibody with resultant damage to tissue. Besides SERUM SICKNESS and the ARTHUS REACTION, evidence supports a pathogenic role for immune complexes in many other IMMUNE SYSTEM DISEASES including GLOMERULONEPHRITIS, systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC) and POLYARTERITIS NODOSA.
A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION.
The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION.
The number of PLATELETS per unit volume in a sample of venous BLOOD.
The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity.
Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template.
The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum.
A human infant born before 37 weeks of GESTATION.
A technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis (usually agarose), then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.
Substances that are recognized by the immune system and induce an immune reaction.
A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.
An infant having a birth weight of 2500 gm. (5.5 lb.) or less but INFANT, VERY LOW BIRTH WEIGHT is available for infants having a birth weight of 1500 grams (3.3 lb.) or less.
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.
A member of the Rho family of MONOMERIC GTP-BINDING PROTEINS. It is associated with a diverse array of cellular functions including cytoskeletal changes, filopodia formation and transport through the GOLGI APPARATUS. This enzyme was formerly listed as EC 3.6.1.47.
INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES.
Steroid hormones produced by the GONADS. They stimulate reproductive organs, germ cell maturation, and the secondary sex characteristics in the males and the females. The major sex steroid hormones include ESTRADIOL; PROGESTERONE; and TESTOSTERONE.
A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.
Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION).
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes.
Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow).
A major protein in the BLOOD. It is important in maintaining the colloidal osmotic pressure and transporting large organic molecules.
Protection from an infectious disease agent that is mediated by B- and T- LYMPHOCYTES following exposure to specific antigen, and characterized by IMMUNOLOGIC MEMORY. It can result from either previous infection with that agent or vaccination (IMMUNITY, ACTIVE), or transfer of antibody or lymphocytes from an immune donor (IMMUNIZATION, PASSIVE).
Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins.
White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS.
Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience.
Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs.
The period following a surgical operation.
Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.
The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
Signaling proteins which function as master molecular switches by activating Rho GTPases through conversion of guanine nucleotides. Rho GTPases in turn control many aspects of cell behavior through the regulation of multiple downstream signal transduction pathways.
The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.)
Stable iodine atoms that have the same atomic number as the element iodine, but differ in atomic weight. I-127 is the only naturally occurring stable iodine isotope.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
The processes triggered by interactions of ANTIBODIES with their ANTIGENS.
A glycoprotein migrating as alpha 1-globulin, molecular weight 70,000 to 120,000. The protein, which is present in increased amounts in the plasma during pregnancy, binds mainly progesterone, with other steroids including testosterone competing weakly.
Any infection which a patient contracts in a health-care institution.
An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed.
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
Established cell cultures that have the potential to propagate indefinitely.
A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species.
A GTP-BINDING PROTEIN involved in regulating a signal transduction pathway that controls assembly of focal adhesions and actin stress fibers. This enzyme was formerly listed as EC 3.6.1.47.
A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally being called a macroglobulin.
An abundantly-expressed rho GDP-dissociation inhibitor subtype that regulates a broad variety of RHO GTPASES.
Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake.
Infections with bacteria of the genus STAPHYLOCOCCUS.
A sub-family of RHO GTP-BINDING PROTEINS that is involved in regulating the organization of cytoskeletal filaments. This enzyme was formerly listed as EC 3.6.1.47.
Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY).
Antibody-mediated immune response. Humoral immunity is brought about by ANTIBODY FORMATION, resulting from TH2 CELLS activating B-LYMPHOCYTES, followed by COMPLEMENT ACTIVATION.
Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
A subcategory of guanine nucleotide dissociation inhibitors that are specific for RHO GTP-BINDING PROTEINS.
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
Abnormal immunoglobulins, especially IGG or IGM, that precipitate spontaneously when SERUM is cooled below 37 degrees Celsius. It is characteristic of CRYOGLOBULINEMIA.
Immunoglobulins produced in a response to BACTERIAL ANTIGENS.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed)
Mechanisms of action and interactions of the components of the IMMUNE SYSTEM.
Toxic proteins produced from the species CLOSTRIDIUM BOTULINUM. The toxins are synthesized as a single peptide chain which is processed into a mature protein consisting of a heavy chain and light chain joined via a disulfide bond. The botulinum toxin light chain is a zinc-dependent protease which is released from the heavy chain upon ENDOCYTOSIS into PRESYNAPTIC NERVE ENDINGS. Once inside the cell the botulinum toxin light chain cleaves specific SNARE proteins which are essential for secretion of ACETYLCHOLINE by SYNAPTIC VESICLES. This inhibition of acetylcholine release results in muscular PARALYSIS.
Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation.
Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals.
A rac GTP-binding protein involved in regulating actin filaments at the plasma membrane. It controls the development of filopodia and lamellipodia in cells and thereby influences cellular motility and adhesion. It is also involved in activation of NADPH OXIDASE. This enzyme was formerly listed as EC 3.6.1.47.
An increased reactivity to specific antigens mediated not by antibodies but by cells.
Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions.
Protein factors that promote the exchange of GTP for GDP bound to GTP-BINDING PROTEINS.
Enzymes that transfer the ADP-RIBOSE group of NAD or NADP to proteins or other small molecules. Transfer of ADP-ribose to water (i.e., hydrolysis) is catalyzed by the NADASES. The mono(ADP-ribose)transferases transfer a single ADP-ribose. POLY(ADP-RIBOSE) POLYMERASES transfer multiple units of ADP-ribose to protein targets, building POLY ADENOSINE DIPHOSPHATE RIBOSE in linear or branched chains.
The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments.
CD4-positive T cells that inhibit immunopathology or autoimmune disease in vivo. They inhibit the immune response by influencing the activity of other cell types. Regulatory T-cells include naturally occurring CD4+CD25+ cells, IL-10 secreting Tr1 cells, and Th3 cells.
Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies.
An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient.
Protein factors that inhibit the dissociation of GDP from GTP-BINDING PROTEINS.
Theoretical representations that simulate the behavior or activity of immune system, processes, or phenomena. They include the use of mathematical equations, computers, and other electrical equipment.
Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation.
Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy.
Subset of helper-inducer T-lymphocytes which synthesize and secrete interleukin-2, gamma-interferon, and interleukin-12. Due to their ability to kill antigen-presenting cells and their lymphokine-mediated effector activity, Th1 cells are associated with vigorous delayed-type hypersensitivity reactions.
Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type.
The circulating form of a major C19 steroid produced primarily by the ADRENAL CORTEX. DHEA sulfate serves as a precursor for TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE.
Nonsusceptibility to the pathogenic effects of foreign microorganisms or antigenic substances as a result of antibody secretions of the mucous membranes. Mucosal epithelia in the gastrointestinal, respiratory, and reproductive tracts produce a form of IgA (IMMUNOGLOBULIN A, SECRETORY) that serves to protect these ports of entry into the body.
The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site.
Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed)
Filamentous proteins that are the main constituent of the thin filaments of muscle fibers. The filaments (known also as filamentous or F-actin) can be dissociated into their globular subunits; each subunit is composed of a single polypeptide 375 amino acids long. This is known as globular or G-actin. In conjunction with MYOSINS, actin is responsible for the contraction and relaxation of muscle.
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
A family of pattern recognition receptors characterized by an extracellular leucine-rich domain and a cytoplasmic domain that share homology with the INTERLEUKIN 1 RECEPTOR and the DROSOPHILA toll protein. Following pathogen recognition, toll-like receptors recruit and activate a variety of SIGNAL TRANSDUCING ADAPTOR PROTEINS.
Immune complex disease caused by the administration of foreign serum or serum proteins and characterized by fever, lymphadenopathy, arthralgia, and urticaria. When they are complexed to protein carriers, some drugs can also cause serum sickness when they act as haptens inducing antibody responses.
The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES).
Sites on an antigen that interact with specific antibodies.
A classification of T-lymphocytes, especially into helper/inducer, suppressor/effector, and cytotoxic subsets, based on structurally or functionally different populations of cells.
Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation.
The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.
They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system.
Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.

1. Foodborne botulism: This type of botulism is caused by eating foods that have been contaminated with the bacteria. Symptoms typically begin within 12 to 72 hours after consuming the contaminated food and can include double vision, droopy eyelids, slurred speech, difficulty swallowing, and muscle weakness.
2. Infant botulism: This type of botulism occurs in infants who are exposed to the bacteria through contact with contaminated soil or object. Symptoms can include constipation, poor feeding, and weak cry.
3. Wound botulism: This type of botulism is caused by the bacteria entering an open wound, usually a deep puncture wound or surgical incision.

Botulism is a rare illness in the United States, but it can be deadly if not treated promptly. Treatment typically involves supportive care, such as mechanical ventilation and fluids, as well as antitoxin injections to neutralize the effects of the toxin. Prevention measures include proper food handling and storage, good hygiene practices, and avoiding consumption of improperly canned or preserved foods.

Vaccinia is most commonly associated with smallpox, which is caused by a similar virus and was eradicated in the late 1970s through widespread vaccination. However, there have been occasional outbreaks of vaccinia in the United States and other countries since then, often linked to laboratory accidents or deliberate releases of the virus.

The treatment of vaccinia typically involves supportive care, such as rest, hydration, and antipyretic medications to reduce fever. Antiviral medications may also be used in some cases. Prevention of the disease relies on avoiding contact with infected animals or people, and on following proper infection control practices in laboratory and healthcare settings.

Vaccinia is a serious viral infection that can have severe consequences if left untreated. It is important to seek medical attention immediately if symptoms persist or worsen over time.

The symptoms of rabies can vary depending on the severity of the infection and the individual's overall health. Early symptoms may include fever, headache, weakness, and fatigue. As the disease progresses, symptoms can become more severe and can include:

* Agitation and confusion
* Seizures and paralysis
* Hydrophobia (fear of water)
* Spasms and twitching
* Increased salivation
* Fever and chills
* Weakness and paralysis of the face, arms, and legs

If left untreated, rabies is almost always fatal. However, prompt medical attention, including the administration of post-exposure prophylaxis (PEP), can prevent the disease from progressing and save the life of an infected person. PEP typically involves a series of injections with rabies immune globulin and a rabies vaccine.

Rabies is a significant public health concern, particularly in developing countries where access to medical care may be limited. According to the World Health Organization (WHO), there are an estimated 55,000-60,000 human deaths from rabies each year, mostly in Asia and Africa. In the United States, rabies is relatively rare, with only a few cases reported each year. However, it is still important for individuals to be aware of the risks of rabies and take precautions to prevent exposure, such as avoiding contact with wild animals and ensuring that pets are up-to-date on their vaccinations.

Hemoglobinuria can be caused by a variety of factors, including:

1. Blood disorders such as sickle cell disease, thalassemia, and von Willebrand disease.
2. Inherited genetic disorders such as hemophilia.
3. Autoimmune disorders such as autoimmune hemolytic anemia.
4. Infections such as septicemia or meningococcemia.
5. Toxins such as lead, which can damage red blood cells and cause hemoglobinuria.
6. Certain medications such as antibiotics and nonsteroidal anti-inflammatory drugs (NSAIDs).
7. Kidney disease or failure.
8. Transfusion-related acute lung injury (TRALI), which can occur after blood transfusions.
9. Hemolytic uremic syndrome (HUS), a condition that occurs when red blood cells are damaged and broken down, leading to kidney failure.

The symptoms of hemoglobinuria may include:

1. Red or brown-colored urine
2. Frequent urination
3. Pale or yellowish skin
4. Fatigue
5. Shortness of breath
6. Nausea and vomiting
7. Headache
8. Dizziness or lightheadedness
9. Confusion or loss of consciousness in severe cases.

Diagnosis of hemoglobinuria is typically made through urine testing, such as a urinalysis, which can detect the presence of hemoglobin in the urine. Additional tests may be ordered to determine the underlying cause of hemoglobinuria, such as blood tests, imaging studies, or biopsies.

Treatment of hemoglobinuria depends on the underlying cause and severity of the condition. In some cases, treatment may involve addressing the underlying condition that is causing the hemoglobinuria, such as managing an infection or stopping certain medications. Other treatments may include:

1. Fluid and electrolyte replacement to prevent dehydration and maintain proper fluid balance.
2. Medications to help remove excess iron from the body.
3. Blood transfusions to increase the number of red blood cells in the body and improve oxygen delivery.
4. Dialysis to filter waste products from the blood when the kidneys are unable to do so.
5. Supportive care, such as oxygen therapy and pain management.

In severe cases of hemoglobinuria, complications can include:

1. Kidney damage or failure
2. Septicemia (blood infection)
3. Respiratory failure
4. Heart problems
5. Increased risk of infections and other complications.

Prevention of hemoglobinuria involves managing any underlying medical conditions, such as diabetes or infections, and avoiding certain medications that can cause the condition. It is also important to seek medical attention if symptoms of hemoglobinuria develop, as early treatment can help prevent complications and improve outcomes.

The exact cause of SPS is not known, but it is believed to be an autoimmune disorder that results in the immune system attacking healthy brain cells, leading to inflammation and damage to the nervous system. Treatment options are limited, and current therapies focus on managing symptoms and improving quality of life.

The definition of Stiff-Person Syndrome (SPS) in the medical field includes:

1. A rare and progressive neurological disorder characterized by muscle stiffness, rigidity, and spasms.
2. Associated with heightened sensitivity to external stimuli such as noise, touch, or emotional stress.
3. Cognitive impairment, anxiety, and depression are common features.
4. Believed to be an autoimmune disorder, causing inflammation and damage to the nervous system.
5. Limited treatment options, with a focus on managing symptoms and improving quality of life.

The main symptoms of PTI include:

* Purple spots or bruises (purpura) on the skin, which may be caused by minor trauma or injury.
* Thrombocytopenia (low platelet count), typically less than 50,000 platelets/mm3.
* Mild anemia and reticulocytosis (increased immature red blood cells).
* Elevated levels of autoantibodies against platelet membrane glycoproteins (GP) and other platelet proteins.
* No evidence of other causes of thrombocytopenia, such as bone marrow disorders or infections.

The exact cause of PTI is unknown, but it is believed to involve an immune-mediated response triggered by a genetic predisposition. Treatment options for PTI include corticosteroids, intravenous immunoglobulin (IVIG), and splenectomy in severe cases. The prognosis for PTI is generally good, with most patients experiencing resolution of symptoms and normalization of platelet counts within a few months to a year after treatment. However, some individuals may experience recurrent episodes of thrombocytopenia and purpura throughout their lives.

The condition is caused by sensitization of the mother's immune system to the Rh factor, which can occur when the mother's blood comes into contact with the fetus's blood during pregnancy or childbirth. The antibodies produced by the mother's immune system can attack the red blood cells of the fetus, leading to hemolytic anemia and potentially causing stillbirth or death in the newborn.

Erythroblastosis fetalis is diagnosed through blood tests that measure the levels of antibodies against the Rh factor. Treatment typically involves the administration of Rh immune globulin, which can help to prevent the mother's immune system from producing more antibodies against the Rh factor and reduce the risk of complications for the fetus. In severe cases, a blood transfusion may be necessary to increase the newborn's red blood cell count.

Erythroblastosis fetalis is a serious condition that requires close monitoring and proper medical management to prevent complications and ensure the best possible outcome for both the mother and the baby.

The symptoms of hepatitis B can range from mild to severe and may include fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, pale stools, joint pain, and jaundice (yellowing of the skin and eyes). In some cases, hepatitis B can be asymptomatic, meaning that individuals may not experience any symptoms at all.

Hepatitis B is diagnosed through blood tests that detect the presence of HBV antigens or antibodies in the body. Treatment for acute hepatitis B typically involves rest, hydration, and medication to manage symptoms, while chronic hepatitis B may require ongoing therapy with antiviral drugs to suppress the virus and prevent liver damage.

Preventive measures for hepatitis B include vaccination, which is recommended for individuals at high risk of infection, such as healthcare workers, sexually active individuals, and those traveling to areas where HBV is common. In addition, safe sex practices, avoiding sharing of needles or other bodily fluids, and proper sterilization of medical equipment can help reduce the risk of transmission.

Overall, hepatitis B is a serious infection that can have long-term consequences for liver health, and it is important to take preventive measures and seek medical attention if symptoms persist or worsen over time.

Hepatitis A is typically spread through contaminated food and water or through close contact with someone who has the infection. The virus can also be spread through sexual contact or sharing of needles.

Symptoms of hepatitis A usually appear two to six weeks after exposure and can last for several weeks or months. In some cases, the infection can lead to complications such as liver failure, which can be life-threatening.

There is a vaccine available for hepatitis A, which is recommended for individuals traveling to areas where the virus is common, people who engage in high-risk behaviors, and those with chronic liver disease. Treatment for hepatitis A typically focuses on relieving symptoms and supporting the liver as it recovers. In severe cases, hospitalization may be necessary.

Preventive measures to reduce the risk of hepatitis A infection include maintaining good hygiene practices, such as washing hands frequently, especially before eating or preparing food; avoiding consumption of raw or undercooked shellfish, particularly oysters; and avoiding close contact with people who have the infection.

People with agammaglobulinemia are more susceptible to infections, particularly those caused by encapsulated bacteria, such as Streptococcus pneumoniae and Haemophilus influenzae type b. They may also experience recurrent sinopulmonary infections, ear infections, and gastrointestinal infections. The disorder can be managed with intravenous immunoglobulin (IVIG) therapy, which provides antibodies to help prevent infections. In severe cases, a bone marrow transplant may be necessary.

Agammaglobulinemia is an autosomal recessive disorder, meaning that a person must inherit two mutated copies of the BTK gene (one from each parent) to develop the condition. It is relatively rare, affecting approximately one in 1 million people worldwide. The disorder can be diagnosed through genetic testing and a complete blood count (CBC) that shows low levels of immunoglobulins.

Treatment for ag

Isoimmunization is a condition that occurs when an individual has antibodies against their own red blood cell antigens, specifically the Rh antigen. This can happen due to various reasons such as:

1. Incompatibility between the mother's and father's Rh antigens, leading to the development of antibodies in the mother during pregnancy or childbirth.
2. Blood transfusions from an incompatible donor.
3. Certain medical conditions like autoimmune hemolytic anemia or bone marrow transplantation.

Rh isoimmunization can lead to a range of complications, including:

1. Hemolytic disease of the newborn: This is a condition where the baby's red blood cells are destroyed by the mother's antibodies, leading to anemia, jaundice, and other serious complications.
2. Rh hemolytic crisis: This is a severe and potentially life-threatening complication that can occur during pregnancy or childbirth.
3. Chronic hemolytic anemia: This is a condition where the red blood cells are continuously destroyed, leading to anemia and other complications.

Rh isoimmunization can be diagnosed through blood tests such as the direct antiglobulin test (DAT) or the indirect Coombs test (ICT). Treatment typically involves managing any underlying conditions and monitoring for complications. In severe cases, a bone marrow transplant may be necessary. Prevention is key, and women who are Rh-negative should receive an injection of Rh immune globulin during pregnancy to prevent the development of antibodies against the Rh antigen.

Some common examples of bacterial infections include:

1. Urinary tract infections (UTIs)
2. Respiratory infections such as pneumonia and bronchitis
3. Skin infections such as cellulitis and abscesses
4. Bone and joint infections such as osteomyelitis
5. Infected wounds or burns
6. Sexually transmitted infections (STIs) such as chlamydia and gonorrhea
7. Food poisoning caused by bacteria such as salmonella and E. coli.

In severe cases, bacterial infections can lead to life-threatening complications such as sepsis or blood poisoning. It is important to seek medical attention if symptoms persist or worsen over time. Proper diagnosis and treatment can help prevent these complications and ensure a full recovery.

Examples of Immunologic Deficiency Syndromes include:

1. Primary Immunodeficiency Diseases (PIDDs): These are a group of genetic disorders that affect the immune system's ability to function properly. Examples include X-linked agammaglobulinemia, common variable immunodeficiency, and severe combined immunodeficiency.
2. Acquired Immunodeficiency Syndrome (AIDS): This is a condition that results from the human immunodeficiency virus (HIV) infection, which destroys CD4 cells, a type of immune cell that fights off infections.
3. Immune Thrombocytopenic Purpura (ITP): This is an autoimmune disorder that causes the immune system to attack and destroy platelets, which are blood cells that help the blood to clot.
4. Autoimmune Disorders: These are conditions in which the immune system mistakenly attacks and damages healthy cells and tissues in the body. Examples include rheumatoid arthritis, lupus, and multiple sclerosis.
5. Immunosuppressive Therapy-induced Immunodeficiency: This is a condition that occurs as a side effect of medications used to prevent rejection in organ transplant patients. These medications can suppress the immune system, increasing the risk of infections.

Symptoms of Immunologic Deficiency Syndromes can vary depending on the specific disorder and the severity of the immune system dysfunction. Common symptoms include recurrent infections, fatigue, fever, and swollen lymph nodes. Treatment options for these syndromes range from medications to suppress the immune system to surgery or bone marrow transplantation.

In summary, Immunologic Deficiency Syndromes are a group of disorders that result from dysfunction of the immune system, leading to recurrent infections and other symptoms. There are many different types of these syndromes, each with its own set of symptoms and treatment options.

There are several types of polyradiculoneuropathy, each with its own set of causes and characteristics:

1. Polyneuropathy: This is the most common type of polyradiculoneuropathy and affects multiple nerves throughout the body. It can be caused by a variety of factors, such as diabetes, vitamin deficiencies, alcoholism, and certain medications.
2. Mononeuritis multiplex: This is a condition in which there is damage to multiple nerves that innervate a specific area of the body, such as the legs or arms. It can be caused by various factors, including diabetes, autoimmune disorders, and certain medications.
3. Radiculoneuropathy: This type of polyradiculoneuropathy affects the nerves that originate from the spinal cord and extend to other parts of the body. It can be caused by compression or inflammation of the nerve roots, such as in the case of herniated discs or spinal stenosis.
4. Autonomic neuropathy: This type of polyradiculoneuropathy affects the nerves that control involuntary functions, such as heart rate, blood pressure, and digestion. It can be caused by a variety of factors, including diabetes, vitamin deficiencies, and certain medications.

The symptoms of polyradiculoneuropathy can vary depending on the specific type and severity of the condition. Common symptoms include:

* Weakness or numbness in the affected areas
* Pain or discomfort in the affected areas
* Difficulty walking or maintaining balance
* Difficulty with fine motor skills, such as buttoning a shirt or tying shoelaces
* Digestive problems, such as constipation or diarrhea
* Urinary incontinence or retention

The diagnosis of polyradiculoneuropathy is typically made based on a combination of physical examination findings, medical history, and results of diagnostic tests such as nerve conduction studies or electromyography. Treatment options for polyradiculoneuropathy depend on the underlying cause of the condition, but may include:

* Medications to manage pain or inflammation
* Physical therapy to improve strength and coordination
* Lifestyle modifications, such as quitting smoking or losing weight, to reduce pressure on the nerves
* Surgery to relieve compression or repair damaged nerves

In some cases, polyradiculoneuropathy may be a symptom of an underlying condition that can be treated or managed with medication or other therapies. It is important to seek medical attention if you experience any symptoms of polyradiculoneuropathy to receive an accurate diagnosis and appropriate treatment.

The symptoms of MCNS typically appear in infancy or early childhood and may include:

* Skin rashes and lesions
* Mucosal lesions (e.g., in the mouth, nose, and eyes)
* Enlarged lymph nodes
* Respiratory problems
* Fevers
* Fatigue

The exact cause of MCNS is not known, but it is believed to be related to an abnormal immune response. The disorder is usually inherited in an autosomal recessive pattern, which means that a child must inherit two copies of the mutated gene (one from each parent) to develop the condition.

There is no cure for MCNS, but treatment may involve medications to manage symptoms and prevent complications. Corticosteroids, immunosuppressive drugs, and antibiotics may be used to reduce inflammation and prevent infection. In severe cases, surgery may be necessary to remove affected tissue or repair deformities.

Prognosis for MCNS varies depending on the severity of the disorder and the presence of any complications. Some individuals with MCNS may experience mild symptoms and have a good quality of life, while others may have more severe symptoms and require ongoing medical care. With appropriate treatment, many individuals with MCNS can lead active and fulfilling lives.

Examples of OIs include:

1. Pneumocystis pneumonia (PCP): A type of pneumonia caused by the fungus Pneumocystis jirovecii, which is commonly found in the lungs of individuals with HIV/AIDS.
2. Cryptococcosis: A fungal infection caused by Cryptococcus neoformans, which can affect various parts of the body, including the lungs, central nervous system, and skin.
3. Aspergillosis: A fungal infection caused by Aspergillus fungi, which can affect various parts of the body, including the lungs, sinuses, and brain.
4. Histoplasmosis: A fungal infection caused by Histoplasma capsulatum, which is commonly found in the soil and can cause respiratory and digestive problems.
5. Candidiasis: A fungal infection caused by Candida albicans, which can affect various parts of the body, including the skin, mouth, throat, and vagina.
6. Toxoplasmosis: A parasitic infection caused by Toxoplasma gondii, which can affect various parts of the body, including the brain, eyes, and lymph nodes.
7. Tuberculosis (TB): A bacterial infection caused by Mycobacterium tuberculosis, which primarily affects the lungs but can also affect other parts of the body.
8. Kaposi's sarcoma-associated herpesvirus (KSHV): A viral infection that can cause various types of cancer, including Kaposi's sarcoma, which is more common in individuals with compromised immunity.

The diagnosis and treatment of OIs depend on the specific type of infection and its severity. Treatment may involve antibiotics, antifungals, or other medications, as well as supportive care to manage symptoms and prevent complications. It is important for individuals with HIV/AIDS to receive prompt and appropriate treatment for OIs to help prevent the progression of their disease and improve their quality of life.

Recurrence can also refer to the re-emergence of symptoms in a previously treated condition, such as a chronic pain condition that returns after a period of remission.

In medical research, recurrence is often studied to understand the underlying causes of disease progression and to develop new treatments and interventions to prevent or delay its return.

Other definitions:

* Premature birth: A birth that occurs before 37 completed weeks of gestation.
* Preterm birth: A birth that occurs before 37 completed weeks of gestation, but not necessarily before 22 weeks.
* Very preterm birth: A birth that occurs before 28 completed weeks of gestation.
* Extremely preterm birth: A birth that occurs before 24 completed weeks of gestation.

Diseases associated with premature infants:

1. Respiratory distress syndrome (RDS): A condition in which the baby's lungs do not produce enough surfactant, a substance that helps the air sacs in the lungs expand and contract properly.
2. Bronchopulmonary dysplasia (BPD): A chronic lung disease that can develop in premature infants who have RDS.
3. Intraventricular hemorrhage (IVH): Bleeding in the brain that can occur in premature infants, particularly those with RDS or BPD.
4. Retinopathy of prematurity (ROP): A condition that can cause blindness in premature infants due to abnormal blood vessel growth in the retina.
5. Necrotizing enterocolitis (NEC): A condition that can cause damage to the intestines and other parts of the digestive system in premature infants.
6. Intracranial hemorrhage (ICH): Bleeding in the brain that can occur in premature infants, particularly those with RDS or BPD.
7. Gastrointestinal problems: Premature infants are at risk for gastroesophageal reflux disease (GERD), necrotizing enterocolitis (NEC), and other gastrointestinal problems.
8. Feeding difficulties: Premature infants may have difficulty feeding, which can lead to weight gain issues or the need for a feeding tube.
9. Respiratory infections: Premature infants are at increased risk for respiratory infections, such as pneumonia and bronchiolitis.
10. Developmental delays: Premature infants may be at risk for developmental delays or learning disabilities, particularly if they experienced significant health problems or required oxygen therapy.

It is important to note that not all premature infants will develop these complications, and the severity of the conditions can vary depending on the individual baby's health and the level of care they receive. However, it is essential for parents and caregivers to be aware of the potential risks and seek prompt medical attention if they notice any signs of distress or illness in their premature infant.

1. Chronic diarrhea
2. Fever
3. Fatigue
4. Night sweats
5. Weight loss
6. Swollen glands in the neck, armpits, or groin
7. Rashes or skin lesions
8. Muscle aches and joint pain
9. Memory loss and other neurological problems
10. Yeast infections in the mouth, throat, or vagina

ARC is a stage of HIV infection that occurs before the development of acquired immunodeficiency syndrome (AIDS). It is characterized by a decline in CD4 cell counts and an increase in HIV viral load. If left untreated, ARC can progress to AIDS, which is a life-threatening condition that affects the body's ability to fight off opportunistic infections and cancers.

The diagnosis of ARC is based on a combination of clinical symptoms, laboratory tests (such as CD4 cell counts and HIV viral load), and medical imaging studies. Treatment for ARC typically involves antiretroviral therapy (ART) to suppress the virus, manage symptoms, and prevent complications.

It's important to note that the term "AIDS-related complex" is no longer used in modern medicine, as it has been replaced by the term "HIV disease." This change reflects the understanding that HIV infection is a continuous spectrum of illness, rather than a distinct set of conditions.

1. Respiratory distress syndrome (RDS): This is a breathing disorder that occurs when the baby's lungs are not fully developed, causing difficulty in breathing. RDS can be treated with oxygen therapy and other medical interventions.
2. Jaundice: Jaundice is a yellowish tint to the skin and eyes caused by high levels of bilirubin in the blood. It is a common condition in newborns, but if left untreated, it can lead to brain damage. Treatment may involve phototherapy or blood exchange transfusions.
3. Neonatal jaundice: This is a milder form of jaundice that occurs in the first few days of life. It usually resolves on its own within a week, but if it persists, treatment may be necessary.
4. Premature birth: Premature babies are at risk for various health issues, including respiratory distress syndrome, intraventricular hemorrhage (bleeding in the brain), and retinopathy (eye problems).
5. Congenital heart disease: This is a heart defect that occurs during fetal development. It can range from mild to severe and may require surgical intervention.
6. Infections: Newborns are susceptible to bacterial and viral infections, such as group B strep, pneumonia, and urinary tract infections. These can be treated with antibiotics if caught early.
7. Hypoglycemia (low blood sugar): This is a condition that occurs when the baby's blood sugar levels drop too low. It can cause seizures, lethargy, and other symptoms. Treatment involves feeding or providing glucose supplements.
8. Hyperbilirubinemia (high bilirubin levels): Bilirubin is a yellow pigment produced during the breakdown of red blood cells. High levels can cause jaundice, which can lead to kernicterus, a condition that can cause brain damage and hearing loss.
9. Intracranial hemorrhage (bleeding in the brain): This is a serious condition that occurs when there is bleeding in the baby's brain. It can be caused by various conditions, including premature birth, abruption, and vasculitis.
10. Meconium aspiration: This occurs when the baby inhales a mixture of meconium (a substance produced by the intestines) and amniotic fluid during delivery. It can cause respiratory problems and other complications.

It's important to note that while these conditions can be serious, many babies born at 37 weeks gestation do not experience any complications. Proper prenatal care and a healthy pregnancy can help reduce the risk of these conditions.

CMV infections are more common in people with weakened immune systems, such as those with HIV/AIDS, cancer, or taking immunosuppressive drugs after an organ transplant. In these individuals, CMV can cause severe and life-threatening complications, such as pneumonia, retinitis (inflammation of the retina), and gastrointestinal disease.

In healthy individuals, CMV infections are usually mild and may not cause any symptoms at all. However, in some cases, CMV can cause a mononucleosis-like illness with fever, fatigue, and swollen lymph nodes.

CMV infections are diagnosed through a combination of physical examination, blood tests, and imaging studies such as CT scans or MRI. Treatment is generally not necessary for mild cases, but may include antiviral medications for more severe infections. Prevention strategies include avoiding close contact with individuals who have CMV, practicing good hygiene, and considering immunoprophylaxis (prevention of infection through the use of immune globulin) for high-risk individuals.

Overall, while CMV infections can be serious and life-threatening, they are relatively rare in healthy individuals and can often be treated effectively with supportive care and antiviral medications.

RSV infections can cause a range of symptoms, including:

* Runny nose
* Decreased appetite
* Coughing
* Sneezing
* Wheezing
* Apnea (pauses in breathing)
* Blue-tinged skin and lips (cyanosis)
* Fever
* Inflammation of the lower respiratory tract (bronchiolitis)
* Pneumonia

In severe cases, RSV infections can lead to hospitalization and may require oxygen therapy or mechanical ventilation. In rare cases, RSV infections can be life-threatening, particularly in premature babies and infants with underlying medical conditions.

There is no specific treatment for RSV infections, but antiviral medications may be prescribed in severe cases. Treatment focuses on relieving symptoms and managing the infection, such as providing hydration and nutrition, administering oxygen therapy, and monitoring vital signs.

Prevention measures for RSV infections include:

* Frequent handwashing, especially after contact with an infected person or their secretions
* Avoiding close contact with anyone who has RSV infection
* Keeping children home from school or daycare if they are showing symptoms of RSV infection
* Practicing good hygiene, such as avoiding sharing utensils or personal items with anyone who is infected

There is currently no vaccine available to protect against RSV infections, but researchers are working on developing one.

There are several types of disease susceptibility, including:

1. Genetic predisposition: This refers to the inherent tendency of an individual to develop a particular disease due to their genetic makeup. For example, some families may have a higher risk of developing certain diseases such as cancer or heart disease due to inherited genetic mutations.
2. Environmental susceptibility: This refers to the increased risk of developing a disease due to exposure to environmental factors such as pollutants, toxins, or infectious agents. For example, someone who lives in an area with high levels of air pollution may be more susceptible to developing respiratory problems.
3. Lifestyle susceptibility: This refers to the increased risk of developing a disease due to unhealthy lifestyle choices such as smoking, lack of exercise, or poor diet. For example, someone who smokes and is overweight may be more susceptible to developing heart disease or lung cancer.
4. Immune system susceptibility: This refers to the increased risk of developing a disease due to an impaired immune system. For example, people with autoimmune disorders such as HIV/AIDS or rheumatoid arthritis may be more susceptible to opportunistic infections.

Understanding disease susceptibility can help healthcare providers identify individuals who are at risk of developing certain diseases and provide preventive measures or early intervention to reduce the risk of disease progression. Additionally, genetic testing can help identify individuals with a high risk of developing certain diseases, allowing for earlier diagnosis and treatment.

In summary, disease susceptibility refers to the predisposition of an individual to develop a particular disease or condition due to various factors such as genetics, environment, lifestyle choices, and immune system function. Understanding disease susceptibility can help healthcare providers identify individuals at risk and provide appropriate preventive measures or early intervention to reduce the risk of disease progression.

The symptoms of AIDS can vary depending on the individual and the stage of the disease. Common symptoms include:

1. Fever
2. Fatigue
3. Swollen glands
4. Rash
5. Muscle aches and joint pain
6. Night sweats
7. Diarrhea
8. Weight loss
9. Memory loss and other neurological problems
10. Cancer and other opportunistic infections.

AIDS is diagnosed through blood tests that detect the presence of HIV antibodies or the virus itself. There is no cure for AIDS, but antiretroviral therapy (ART) can help manage the symptoms and slow the progression of the disease. Prevention methods include using condoms, pre-exposure prophylaxis (PrEP), and avoiding sharing needles or other injection equipment.

In summary, Acquired Immunodeficiency Syndrome (AIDS) is a severe and life-threatening condition caused by the Human Immunodeficiency Virus (HIV). It is characterized by a severely weakened immune system, which makes it difficult to fight off infections and diseases. While there is no cure for AIDS, antiretroviral therapy can help manage the symptoms and slow the progression of the disease. Prevention methods include using condoms, pre-exposure prophylaxis, and avoiding sharing needles or other injection equipment.

The term "immune complex disease" was first used in the 1960s to describe a group of conditions that were thought to be caused by the formation of immune complexes. These diseases include:

1. Systemic lupus erythematosus (SLE): an autoimmune disorder that can affect multiple organ systems and is characterized by the presence of anti-nuclear antibodies.
2. Rheumatoid arthritis (RA): an autoimmune disease that causes inflammation in the joints and can lead to joint damage.
3. Type III hypersensitivity reaction: a condition in which immune complexes are deposited in tissues, leading to inflammation and tissue damage.
4. Pemphigus: a group of autoimmune diseases that affect the skin and mucous membranes, characterized by the presence of autoantibodies against desmosomal antigens.
5. Bullous pemphigoid: an autoimmune disease that affects the skin and is characterized by the formation of large blisters.
6. Myasthenia gravis: an autoimmune disorder that affects the nervous system, causing muscle weakness and fatigue.
7. Goodpasture's syndrome: a rare autoimmune disease that affects the kidneys and lungs, characterized by the presence of immune complexes in the glomeruli of the kidneys.
8. Hemolytic uremic syndrome (HUS): a condition in which red blood cells are destroyed and waste products accumulate in the kidneys, leading to kidney failure.

Immune complex diseases can be caused by various factors, including genetic predisposition, environmental triggers, and exposure to certain drugs or toxins. Treatment options for these diseases include medications that suppress the immune system, such as corticosteroids and immunosuppressive drugs, and plasmapheresis, which is a process that removes harmful antibodies from the blood. In some cases, organ transplantation may be necessary.

In conclusion, immune complex diseases are a group of disorders that occur when the body's immune system mistakenly attacks its own tissues and organs, leading to inflammation and damage. These diseases can affect various parts of the body, including the skin, kidneys, lungs, and nervous system. Treatment options vary depending on the specific disease and its severity, but may include medications that suppress the immune system and plasmapheresis.

Symptoms of aplastic anemia may include fatigue, weakness, shortness of breath, pale skin, and increased risk of bleeding or infection. Treatment options for aplastic anemia typically involve blood transfusions and immunosuppressive drugs to stimulate the bone marrow to produce new blood cells. In severe cases, a bone marrow transplant may be necessary.

Overall, aplastic anemia is a rare and serious condition that requires careful management by a healthcare provider to prevent complications and improve quality of life.

1. Group B streptococcus (GBS): This type of bacterial infection is the leading cause of infections in newborns. GBS can cause a range of complications, including pneumonia, meningitis, and sepsis.
2. Urinary tract infections (UTIs): These are common during pregnancy and can be caused by bacteria such as Escherichia coli (E. coli) or Staphylococcus saprophyticus. UTIs can lead to complications such as preterm labor and low birth weight.
3. HIV: Pregnant women who are infected with HIV can pass the virus to their baby during pregnancy, childbirth, or breastfeeding.
4. Toxoplasmosis: This is an infection caused by a parasite that can be transmitted to the fetus through the placenta. Toxoplasmosis can cause a range of complications, including birth defects and stillbirth.
5. Listeriosis: This is a rare infection caused by eating contaminated food, such as soft cheeses or hot dogs. Listeriosis can cause complications such as miscarriage, stillbirth, and premature labor.
6. Influenza: Pregnant women who contract the flu can be at higher risk for complications such as pneumonia and hospitalization.
7. Herpes simplex virus (HSV): This virus can cause complications such as preterm labor, low birth weight, and neonatal herpes.
8. Human parvovirus (HPV): This virus can cause complications such as preterm labor, low birth weight, and stillbirth.
9. Syphilis: This is a sexually transmitted infection that can be passed to the fetus during pregnancy, leading to complications such as stillbirth, premature birth, and congenital syphilis.
10. Chickenpox: Pregnant women who contract chickenpox can be at higher risk for complications such as preterm labor and low birth weight.

It's important to note that the risks associated with these infections are relatively low, and many pregnant women who contract them will have healthy pregnancies and healthy babies. However, it's still important to be aware of the risks and take steps to protect yourself and your baby.

Here are some ways to reduce your risk of infection during pregnancy:

1. Practice good hygiene: Wash your hands frequently, especially before preparing or eating food.
2. Avoid certain foods: Avoid consuming raw or undercooked meat, eggs, and dairy products, as well as unpasteurized juices and soft cheeses.
3. Get vaccinated: Get vaccinated against infections such as the flu and HPV.
4. Practice safe sex: Use condoms or other forms of barrier protection to prevent the spread of STIs.
5. Avoid close contact with people who are sick: If someone in your household is sick, try to avoid close contact with them if possible.
6. Keep your environment clean: Regularly clean and disinfect surfaces and objects that may be contaminated with germs.
7. Manage stress: High levels of stress can weaken your immune system and make you more susceptible to infection.
8. Get enough rest: Adequate sleep is essential for maintaining a healthy immune system.
9. Stay hydrated: Drink plenty of water throughout the day to help flush out harmful bacteria and viruses.
10. Consider taking prenatal vitamins: Prenatal vitamins can help support your immune system and overall health during pregnancy.

Remember, it's always better to be safe than sorry, so if you suspect that you may have been exposed to an infection or are experiencing symptoms of an infection during pregnancy, contact your healthcare provider right away. They can help determine the appropriate course of action and ensure that you and your baby stay healthy.

1. Autoimmune diseases: These occur when the immune system mistakenly attacks healthy cells and tissues in the body. Examples include rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes.
2. Allergies: An allergic reaction occurs when the immune system overreacts to a harmless substance, such as pollen, dust mites, or certain foods. Symptoms can range from mild hives to life-threatening anaphylaxis.
3. Immunodeficiency disorders: These are conditions that impair the immune system's ability to fight infections. Examples include HIV/AIDS and primary immunodeficiency diseases.
4. Infectious diseases: Certain infections, such as tuberculosis or bacterial meningitis, can cause immune system dysfunction.
5. Cancer: Some types of cancer, such as lymphoma, affect the immune system's ability to fight disease.
6. Immune thrombocytopenic purpura (ITP): This is a rare autoimmune disorder that causes the immune system to attack and destroy platelets, leading to bleeding and bruising.
7. Guillain-Barré syndrome: This is a rare autoimmune disorder that occurs when the immune system attacks the nerves, leading to muscle weakness and paralysis.
8. Chronic fatigue syndrome (CFS): This is a condition characterized by persistent fatigue, muscle pain, and joint pain, which is thought to be related to an immune system imbalance.
9. Fibromyalgia: This is a chronic condition characterized by widespread muscle pain, fatigue, and sleep disturbances, which may be linked to immune system dysfunction.
10. Autoimmune hepatitis: This is a condition in which the immune system attacks the liver, leading to inflammation and damage to the liver cells.

It's important to note that a weakened immune system can increase the risk of infections and other health problems, so it's important to work with your healthcare provider to identify any underlying causes and develop an appropriate treatment plan.

There are several types of hepatitis C, including genotype 1, which is the most common and accounts for approximately 70% of cases in the United States. Other genotypes include 2, 3, 4, 5, and 6. The symptoms of hepatitis C can range from mild to severe and may include fatigue, fever, loss of appetite, nausea, vomiting, joint pain, jaundice (yellowing of the skin and eyes), dark urine, pale stools, and itching all over the body. Some people with hepatitis C may not experience any symptoms at all.

Hepatitis C is diagnosed through a combination of blood tests that detect the presence of antibodies against HCV or the virus itself. Treatment typically involves a combination of medications, including interferon and ribavirin, which can cure the infection but may have side effects such as fatigue, nausea, and depression. In recent years, new drugs known as direct-acting antivirals (DAAs) have become available, which can cure the infection with fewer side effects and in a shorter period of time.

Prevention measures for hepatitis C include avoiding sharing needles or other drug paraphernalia, using condoms to prevent sexual transmission, and ensuring that any tattoos or piercings are performed with sterilized equipment. Vaccines are also available for people who are at high risk of contracting the virus, such as healthcare workers and individuals who engage in high-risk behaviors.

Overall, hepatitis C is a serious and common liver disease that can lead to significant health complications if left untreated. Fortunately, with advances in medical technology and treatment options, it is possible to manage and cure the virus with proper care and attention.

In medicine, cross-infection refers to the transmission of an infectious agent from one individual or source to another, often through direct contact or indirect exposure. This type of transmission can occur in various settings, such as hospitals, clinics, and long-term care facilities, where patients with compromised immune systems are more susceptible to infection.

Cross-infection can occur through a variety of means, including:

1. Person-to-person contact: Direct contact with an infected individual, such as touching, hugging, or shaking hands.
2. Contaminated surfaces and objects: Touching contaminated surfaces or objects that have been touched by an infected individual, such as doorknobs, furniture, or medical equipment.
3. Airborne transmission: Inhaling droplets or aerosolized particles that contain the infectious agent, such as during coughing or sneezing.
4. Contaminated food and water: Consuming food or drinks that have been handled by an infected individual or contaminated with the infectious agent.
5. Insect vectors: Mosquitoes, ticks, or other insects can transmit infections through their bites.

Cross-infection is a significant concern in healthcare settings, as it can lead to outbreaks of nosocomial infections (infections acquired in hospitals) and can spread rapidly among patients, healthcare workers, and visitors. To prevent cross-infection, healthcare providers use strict infection control measures, such as wearing personal protective equipment (PPE), thoroughly cleaning and disinfecting surfaces, and implementing isolation precautions for infected individuals.

In summary, cross-infection refers to the transmission of an infectious agent from one individual or source to another, often through direct contact or indirect exposure in healthcare settings. Preventing cross-infection is essential to maintaining a safe and healthy environment for patients, healthcare workers, and visitors.

Staphylococcal infections can be classified into two categories:

1. Methicillin-Resistant Staphylococcus Aureus (MRSA) - This type of infection is resistant to many antibiotics and can cause severe skin infections, pneumonia, bloodstream infections and surgical site infections.

2. Methicillin-Sensitive Staphylococcus Aureus (MSSA) - This type of infection is not resistant to antibiotics and can cause milder skin infections, respiratory tract infections, sinusitis and food poisoning.

Staphylococcal infections are caused by the Staphylococcus bacteria which can enter the body through various means such as:

1. Skin cuts or open wounds
2. Respiratory tract infections
3. Contaminated food and water
4. Healthcare-associated infections
5. Surgical site infections

Symptoms of Staphylococcal infections may vary depending on the type of infection and severity, but they can include:

1. Skin redness and swelling
2. Increased pain or tenderness
3. Warmth or redness in the affected area
4. Pus or discharge
5. Fever and chills
6. Swollen lymph nodes
7. Shortness of breath

Diagnosis of Staphylococcal infections is based on physical examination, medical history, laboratory tests such as blood cultures, and imaging studies such as X-rays or CT scans.

Treatment of Staphylococcal infections depends on the type of infection and severity, but may include:

1. Antibiotics to fight the infection
2. Drainage of abscesses or pus collection
3. Wound care and debridement
4. Supportive care such as intravenous fluids, oxygen therapy, and pain management
5. Surgical intervention in severe cases.

Preventive measures for Staphylococcal infections include:

1. Good hand hygiene practices
2. Proper cleaning and disinfection of surfaces and equipment
3. Avoiding close contact with people who have Staphylococcal infections
4. Covering wounds and open sores
5. Proper sterilization and disinfection of medical equipment.

It is important to note that MRSA (methicillin-resistant Staphylococcus aureus) is a type of Staphylococcal infection that is resistant to many antibiotics, and can be difficult to treat. Therefore, early diagnosis and aggressive treatment are crucial to prevent complications and improve outcomes.

1) They share similarities with humans: Many animal species share similar biological and physiological characteristics with humans, making them useful for studying human diseases. For example, mice and rats are often used to study diseases such as diabetes, heart disease, and cancer because they have similar metabolic and cardiovascular systems to humans.

2) They can be genetically manipulated: Animal disease models can be genetically engineered to develop specific diseases or to model human genetic disorders. This allows researchers to study the progression of the disease and test potential treatments in a controlled environment.

3) They can be used to test drugs and therapies: Before new drugs or therapies are tested in humans, they are often first tested in animal models of disease. This allows researchers to assess the safety and efficacy of the treatment before moving on to human clinical trials.

4) They can provide insights into disease mechanisms: Studying disease models in animals can provide valuable insights into the underlying mechanisms of a particular disease. This information can then be used to develop new treatments or improve existing ones.

5) Reduces the need for human testing: Using animal disease models reduces the need for human testing, which can be time-consuming, expensive, and ethically challenging. However, it is important to note that animal models are not perfect substitutes for human subjects, and results obtained from animal studies may not always translate to humans.

6) They can be used to study infectious diseases: Animal disease models can be used to study infectious diseases such as HIV, TB, and malaria. These models allow researchers to understand how the disease is transmitted, how it progresses, and how it responds to treatment.

7) They can be used to study complex diseases: Animal disease models can be used to study complex diseases such as cancer, diabetes, and heart disease. These models allow researchers to understand the underlying mechanisms of the disease and test potential treatments.

8) They are cost-effective: Animal disease models are often less expensive than human clinical trials, making them a cost-effective way to conduct research.

9) They can be used to study drug delivery: Animal disease models can be used to study drug delivery and pharmacokinetics, which is important for developing new drugs and drug delivery systems.

10) They can be used to study aging: Animal disease models can be used to study the aging process and age-related diseases such as Alzheimer's and Parkinson's. This allows researchers to understand how aging contributes to disease and develop potential treatments.

There are several key features of inflammation:

1. Increased blood flow: Blood vessels in the affected area dilate, allowing more blood to flow into the tissue and bringing with it immune cells, nutrients, and other signaling molecules.
2. Leukocyte migration: White blood cells, such as neutrophils and monocytes, migrate towards the site of inflammation in response to chemical signals.
3. Release of mediators: Inflammatory mediators, such as cytokines and chemokines, are released by immune cells and other cells in the affected tissue. These molecules help to coordinate the immune response and attract more immune cells to the site of inflammation.
4. Activation of immune cells: Immune cells, such as macrophages and T cells, become activated and start to phagocytose (engulf) pathogens or damaged tissue.
5. Increased heat production: Inflammation can cause an increase in metabolic activity in the affected tissue, leading to increased heat production.
6. Redness and swelling: Increased blood flow and leakiness of blood vessels can cause redness and swelling in the affected area.
7. Pain: Inflammation can cause pain through the activation of nociceptors (pain-sensing neurons) and the release of pro-inflammatory mediators.

Inflammation can be acute or chronic. Acute inflammation is a short-term response to injury or infection, which helps to resolve the issue quickly. Chronic inflammation is a long-term response that can cause ongoing damage and diseases such as arthritis, asthma, and cancer.

There are several types of inflammation, including:

1. Acute inflammation: A short-term response to injury or infection.
2. Chronic inflammation: A long-term response that can cause ongoing damage and diseases.
3. Autoimmune inflammation: An inappropriate immune response against the body's own tissues.
4. Allergic inflammation: An immune response to a harmless substance, such as pollen or dust mites.
5. Parasitic inflammation: An immune response to parasites, such as worms or fungi.
6. Bacterial inflammation: An immune response to bacteria.
7. Viral inflammation: An immune response to viruses.
8. Fungal inflammation: An immune response to fungi.

There are several ways to reduce inflammation, including:

1. Medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying anti-rheumatic drugs (DMARDs).
2. Lifestyle changes, such as a healthy diet, regular exercise, stress management, and getting enough sleep.
3. Alternative therapies, such as acupuncture, herbal supplements, and mind-body practices.
4. Addressing underlying conditions, such as hormonal imbalances, gut health issues, and chronic infections.
5. Using anti-inflammatory compounds found in certain foods, such as omega-3 fatty acids, turmeric, and ginger.

It's important to note that chronic inflammation can lead to a range of health problems, including:

1. Arthritis
2. Diabetes
3. Heart disease
4. Cancer
5. Alzheimer's disease
6. Parkinson's disease
7. Autoimmune disorders, such as lupus and rheumatoid arthritis.

Therefore, it's important to manage inflammation effectively to prevent these complications and improve overall health and well-being.

Examples of delayed hypersensitivity reactions include contact dermatitis (a skin reaction to an allergic substance), tuberculin reactivity (a reaction to the bacteria that cause tuberculosis), and sarcoidosis (a condition characterized by inflammation in various organs, including the lungs and lymph nodes).

Delayed hypersensitivity reactions are important in the diagnosis and management of allergic disorders and other immune-related conditions. They can be detected through a variety of tests, including skin prick testing, patch testing, and blood tests. Treatment for delayed hypersensitivity reactions depends on the underlying cause and may involve medications such as antihistamines, corticosteroids, or immunosuppressants.

The term "serum sickness" was first used in the late 19th century to describe this condition, which was often seen in people who had received serum (a type of blood product) containing antibodies against diseases such as diphtheria or tetanus. Today, the term is still used to describe similar reactions to other substances, including medications and vaccines.

Serum sickness can be mild or severe, and in rare cases, it can lead to serious complications such as kidney failure or inflammation of the heart. Treatment typically involves stopping the use of the offending substance and providing supportive care to manage symptoms. In severe cases, corticosteroids or other medications may be used to reduce inflammation.

While serum sickness is a relatively rare condition, it is important for healthcare providers to be aware of it as a potential complication of medication and vaccine use. This knowledge can help them recognize and manage the condition effectively, reducing the risk of serious complications and improving outcomes for patients.

The symptoms of glomerulonephritis can vary depending on the underlying cause of the disease, but may include:

* Blood in the urine (hematuria)
* Proteinuria (excess protein in the urine)
* Reduced kidney function
* Swelling in the legs and ankles (edema)
* High blood pressure

Glomerulonephritis can be caused by a variety of factors, including:

* Infections such as staphylococcal or streptococcal infections
* Autoimmune disorders such as lupus or rheumatoid arthritis
* Allergic reactions to certain medications
* Genetic defects
* Certain diseases such as diabetes, high blood pressure, and sickle cell anemia

The diagnosis of glomerulonephritis typically involves a physical examination, medical history, and laboratory tests such as urinalysis, blood tests, and kidney biopsy.

Treatment for glomerulonephritis depends on the underlying cause of the disease and may include:

* Antibiotics to treat infections
* Medications to reduce inflammation and swelling
* Diuretics to reduce fluid buildup in the body
* Immunosuppressive medications to suppress the immune system in cases of autoimmune disorders
* Dialysis in severe cases

The prognosis for glomerulonephritis depends on the underlying cause of the disease and the severity of the inflammation. In some cases, the disease may progress to end-stage renal disease, which requires dialysis or a kidney transplant. With proper treatment, however, many people with glomerulonephritis can experience a good outcome and maintain their kidney function over time.

The symptoms of hypoproteinemia can vary depending on the underlying cause and severity of the condition. Some common symptoms include:

1. Weakness and fatigue
2. Loss of appetite
3. Nausea and vomiting
4. Diarrhea or constipation
5. Skin, hair, and nail problems
6. Increased risk of infections
7. Muscle wasting and loss of muscle mass
8. Poor wound healing
9. Hair loss
10. Edema (swelling)

If you suspect that you or someone you know may have hypoproteinemia, it is important to consult a healthcare professional for proper diagnosis and treatment. A healthcare provider will typically perform a physical examination, take a medical history, and order blood tests to determine the levels of protein and other essential nutrients in the body.

Treatment of hypoproteinemia depends on the underlying cause of the condition. In cases where the condition is caused by malnutrition or dietary deficiencies, dietary modifications and supplements may be recommended. For example, a patient with hypoproteinemia due to malnutrition may need to consume more protein-rich foods, such as meat, poultry, fish, eggs, dairy products, legumes, and nuts. In cases where the condition is caused by an underlying medical condition, such as liver or kidney disease, treatment may involve managing the underlying condition.

It is important to note that hypoproteinemia can lead to serious complications if left untreated, such as muscle wasting, poor wound healing, and increased risk of infections. Therefore, it is crucial to seek medical attention if you suspect that you or someone you know may have hypoproteinemia.

In summary, hypoproteinemia is a condition characterized by low levels of protein in the blood. It can be caused by various factors, such as malnutrition, liver or kidney disease, and other medical conditions. Treatment options depend on the underlying cause of the condition, and early diagnosis and treatment are crucial to prevent complications. If you suspect that you or someone you know may have hypoproteinemia, it is essential to consult a healthcare professional for proper diagnosis and treatment.

Examples of autoimmune diseases include:

1. Rheumatoid arthritis (RA): A condition where the immune system attacks the joints, leading to inflammation, pain, and joint damage.
2. Lupus: A condition where the immune system attacks various body parts, including the skin, joints, and organs.
3. Hashimoto's thyroiditis: A condition where the immune system attacks the thyroid gland, leading to hypothyroidism.
4. Multiple sclerosis (MS): A condition where the immune system attacks the protective covering of nerve fibers in the central nervous system, leading to communication problems between the brain and the rest of the body.
5. Type 1 diabetes: A condition where the immune system attacks the insulin-producing cells in the pancreas, leading to high blood sugar levels.
6. Guillain-Barré syndrome: A condition where the immune system attacks the nerves, leading to muscle weakness and paralysis.
7. Psoriasis: A condition where the immune system attacks the skin, leading to red, scaly patches.
8. Crohn's disease and ulcerative colitis: Conditions where the immune system attacks the digestive tract, leading to inflammation and damage to the gut.
9. Sjögren's syndrome: A condition where the immune system attacks the glands that produce tears and saliva, leading to dry eyes and mouth.
10. Vasculitis: A condition where the immune system attacks the blood vessels, leading to inflammation and damage to the blood vessels.

The symptoms of autoimmune diseases vary depending on the specific disease and the organs or tissues affected. Common symptoms include fatigue, fever, joint pain, skin rashes, and swollen lymph nodes. Treatment for autoimmune diseases typically involves medication to suppress the immune system and reduce inflammation, as well as lifestyle changes such as dietary changes and stress management techniques.

Types of Infection:

1. Bacterial Infections: These are caused by the presence of harmful bacteria in the body. Examples include pneumonia, urinary tract infections, and skin infections.
2. Viral Infections: These are caused by the presence of harmful viruses in the body. Examples include the common cold, flu, and HIV/AIDS.
3. Fungal Infections: These are caused by the presence of fungi in the body. Examples include athlete's foot, ringworm, and candidiasis.
4. Parasitic Infections: These are caused by the presence of parasites in the body. Examples include malaria, giardiasis, and toxoplasmosis.

Symptoms of Infection:

1. Fever
2. Fatigue
3. Headache
4. Muscle aches
5. Skin rashes or lesions
6. Swollen lymph nodes
7. Sore throat
8. Coughing
9. Diarrhea
10. Vomiting

Treatment of Infection:

1. Antibiotics: These are used to treat bacterial infections and work by killing or stopping the growth of bacteria.
2. Antiviral medications: These are used to treat viral infections and work by interfering with the replication of viruses.
3. Fungicides: These are used to treat fungal infections and work by killing or stopping the growth of fungi.
4. Anti-parasitic medications: These are used to treat parasitic infections and work by killing or stopping the growth of parasites.
5. Supportive care: This includes fluids, nutritional supplements, and pain management to help the body recover from the infection.

Prevention of Infection:

1. Hand washing: Regular hand washing is one of the most effective ways to prevent the spread of infection.
2. Vaccination: Getting vaccinated against specific infections can help prevent them.
3. Safe sex practices: Using condoms and other safe sex practices can help prevent the spread of sexually transmitted infections.
4. Food safety: Properly storing and preparing food can help prevent the spread of foodborne illnesses.
5. Infection control measures: Healthcare providers use infection control measures such as wearing gloves, masks, and gowns to prevent the spread of infections in healthcare settings.

There are several types of blood protein disorders, including:

1. Hemophilia A: a deficiency of factor VIII, which is necessary for blood clotting.
2. Hemophilia B: a deficiency of factor IX, also involved in blood clotting.
3. Von Willebrand disease: a deficiency of von Willebrand factor, which helps to platelets stick together and form blood clots.
4. Protein C deficiency: a lack of protein C, an anticoagulant protein that helps to prevent blood clots.
5. Protein S deficiency: a lack of protein S, another anticoagulant protein that helps to prevent blood clots.
6. Antithrombin III deficiency: a lack of antithrombin III, a protein that prevents the formation of blood clots.
7. Fibrinogen deficiency: a lack of fibrinogen, a protein that is essential for blood clotting.
8. Dysproteinemia: an abnormal amount or type of proteins in the blood, which can lead to various symptoms and complications.

Symptoms of blood protein disorders can vary depending on the specific condition and the severity of the deficiency. Common symptoms include easy bruising or bleeding, frequent nosebleeds, prolonged bleeding after injuries or surgery, and joint pain or swelling.

Treatment for blood protein disorders typically involves replacing the missing protein or managing symptoms with medication or lifestyle changes. In some cases, gene therapy may be an option to correct the underlying genetic defect.

It's important for individuals with blood protein disorders to work closely with their healthcare provider to manage their condition and prevent complications such as joint damage, infections, and bleeding episodes.

The condition is characterized by an exaggerated immune response, which can cause inflammation in various parts of the body, including the skin, eyes, lungs, and gastrointestinal tract. IRIS can manifest as a range of symptoms, such as fever, fatigue, pain, and swelling in the affected areas.

The exact cause of IRIS is not fully understood, but it is thought to be related to the restoration of immune function after being suppressed by HIV. When ART is initiated, the immune system begins to recover, and the body mounts an immune response against previously latent viral reservoirs. This can lead to inflammation and tissue damage in some individuals.

The diagnosis of IRIS is based on a combination of clinical findings, laboratory tests, and imaging studies. Treatment typically involves supportive care, such as antibiotics for bacterial infections, anti-inflammatory medications, and corticosteroids to reduce inflammation. In severe cases, hospitalization may be necessary.

Prevention strategies for IRIS include careful monitoring of patients on ART, early detection and treatment of opportunistic infections, and the use of corticosteroids to prevent or treat inflammation. It is important for healthcare providers to be aware of the risk of IRIS and to monitor patients closely, particularly during the early stages of ART. With appropriate management, most cases of IRIS resolve without long-term complications.

HIV (human immunodeficiency virus) infection is a condition in which the body is infected with HIV, a type of retrovirus that attacks the body's immune system. HIV infection can lead to AIDS (acquired immunodeficiency syndrome), a condition in which the immune system is severely damaged and the body is unable to fight off infections and diseases.

There are several ways that HIV can be transmitted, including:

1. Sexual contact with an infected person
2. Sharing of needles or other drug paraphernalia with an infected person
3. Mother-to-child transmission during pregnancy, childbirth, or breastfeeding
4. Blood transfusions ( although this is rare in developed countries due to screening processes)
5. Organ transplantation (again, rare)

The symptoms of HIV infection can be mild at first and may not appear until several years after infection. These symptoms can include:

1. Fever
2. Fatigue
3. Swollen glands in the neck, armpits, and groin
4. Rash
5. Muscle aches and joint pain
6. Night sweats
7. Diarrhea
8. Weight loss

If left untreated, HIV infection can progress to AIDS, which is a life-threatening condition that can cause a wide range of symptoms, including:

1. Opportunistic infections (such as pneumocystis pneumonia)
2. Cancer (such as Kaposi's sarcoma)
3. Wasting syndrome
4. Neurological problems (such as dementia and seizures)

HIV infection is diagnosed through a combination of blood tests and physical examination. Treatment typically involves antiretroviral therapy (ART), which is a combination of medications that work together to suppress the virus and slow the progression of the disease.

Prevention methods for HIV infection include:

1. Safe sex practices, such as using condoms and dental dams
2. Avoiding sharing needles or other drug-injecting equipment
3. Avoiding mother-to-child transmission during pregnancy, childbirth, or breastfeeding
4. Post-exposure prophylaxis (PEP), which is a short-term treatment that can prevent infection after potential exposure to the virus
5. Pre-exposure prophylaxis (PrEP), which is a daily medication that can prevent infection in people who are at high risk of being exposed to the virus.

It's important to note that HIV infection is manageable with proper treatment and care, and that people living with HIV can lead long and healthy lives. However, it's important to be aware of the risks and take steps to prevent transmission.

The diagnosis of GVHD is based on a combination of clinical findings, laboratory tests, and biopsies. Treatment options include immunosuppressive drugs, corticosteroids, and in severe cases, stem cell transplantation reversal or donor lymphocyte infusion.

Prevention of GVHD includes selecting the right donor, using conditioning regimens that minimize damage to the recipient's bone marrow, and providing appropriate immunosuppression after transplantation. Early detection and management of GVHD are critical to prevent long-term complications and improve survival rates.

Neoplasm refers to an abnormal growth of cells that can be benign (non-cancerous) or malignant (cancerous). Neoplasms can occur in any part of the body and can affect various organs and tissues. The term "neoplasm" is often used interchangeably with "tumor," but while all tumors are neoplasms, not all neoplasms are tumors.

Types of Neoplasms

There are many different types of neoplasms, including:

1. Carcinomas: These are malignant tumors that arise in the epithelial cells lining organs and glands. Examples include breast cancer, lung cancer, and colon cancer.
2. Sarcomas: These are malignant tumors that arise in connective tissue, such as bone, cartilage, and fat. Examples include osteosarcoma (bone cancer) and soft tissue sarcoma.
3. Lymphomas: These are cancers of the immune system, specifically affecting the lymph nodes and other lymphoid tissues. Examples include Hodgkin lymphoma and non-Hodgkin lymphoma.
4. Leukemias: These are cancers of the blood and bone marrow that affect the white blood cells. Examples include acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL).
5. Melanomas: These are malignant tumors that arise in the pigment-producing cells called melanocytes. Examples include skin melanoma and eye melanoma.

Causes and Risk Factors of Neoplasms

The exact causes of neoplasms are not fully understood, but there are several known risk factors that can increase the likelihood of developing a neoplasm. These include:

1. Genetic predisposition: Some people may be born with genetic mutations that increase their risk of developing certain types of neoplasms.
2. Environmental factors: Exposure to certain environmental toxins, such as radiation and certain chemicals, can increase the risk of developing a neoplasm.
3. Infection: Some neoplasms are caused by viruses or bacteria. For example, human papillomavirus (HPV) is a common cause of cervical cancer.
4. Lifestyle factors: Factors such as smoking, excessive alcohol consumption, and a poor diet can increase the risk of developing certain types of neoplasms.
5. Family history: A person's risk of developing a neoplasm may be higher if they have a family history of the condition.

Signs and Symptoms of Neoplasms

The signs and symptoms of neoplasms can vary depending on the type of cancer and where it is located in the body. Some common signs and symptoms include:

1. Unusual lumps or swelling
2. Pain
3. Fatigue
4. Weight loss
5. Change in bowel or bladder habits
6. Unexplained bleeding
7. Coughing up blood
8. Hoarseness or a persistent cough
9. Changes in appetite or digestion
10. Skin changes, such as a new mole or a change in the size or color of an existing mole.

Diagnosis and Treatment of Neoplasms

The diagnosis of a neoplasm usually involves a combination of physical examination, imaging tests (such as X-rays, CT scans, or MRI scans), and biopsy. A biopsy involves removing a small sample of tissue from the suspected tumor and examining it under a microscope for cancer cells.

The treatment of neoplasms depends on the type, size, location, and stage of the cancer, as well as the patient's overall health. Some common treatments include:

1. Surgery: Removing the tumor and surrounding tissue can be an effective way to treat many types of cancer.
2. Chemotherapy: Using drugs to kill cancer cells can be effective for some types of cancer, especially if the cancer has spread to other parts of the body.
3. Radiation therapy: Using high-energy radiation to kill cancer cells can be effective for some types of cancer, especially if the cancer is located in a specific area of the body.
4. Immunotherapy: Boosting the body's immune system to fight cancer can be an effective treatment for some types of cancer.
5. Targeted therapy: Using drugs or other substances to target specific molecules on cancer cells can be an effective treatment for some types of cancer.

Prevention of Neoplasms

While it is not always possible to prevent neoplasms, there are several steps that can reduce the risk of developing cancer. These include:

1. Avoiding exposure to known carcinogens (such as tobacco smoke and radiation)
2. Maintaining a healthy diet and lifestyle
3. Getting regular exercise
4. Not smoking or using tobacco products
5. Limiting alcohol consumption
6. Getting vaccinated against certain viruses that are associated with cancer (such as human papillomavirus, or HPV)
7. Participating in screening programs for early detection of cancer (such as mammograms for breast cancer and colonoscopies for colon cancer)
8. Avoiding excessive exposure to sunlight and using protective measures such as sunscreen and hats to prevent skin cancer.

It's important to note that not all cancers can be prevented, and some may be caused by factors that are not yet understood or cannot be controlled. However, by taking these steps, individuals can reduce their risk of developing cancer and improve their overall health and well-being.

Rho(D)+Immune+Globulin at the US National Library of Medicine Medical Subject Headings (MeSH) "Rho(D) Immune Globulin". Drug ... Rho(D) immune globulin is made up of antibodies to the antigen Rho(D) present on some red blood cells. It is believed to work ... Rho(D) Immune Globulin Intravenous [Human; Anti-D] is indicated for use in non-splenectomized, Rho(D)-positive children with ... immune globulin is also spelled Rh0(D) immune globulin (letter o and digit zero are both widely attested; more at Rh blood ...
Rho(D) immune globulin antibodies are specific for human RhD antigen. Anti-RhD antibodies are administered as part of a ... Rho(D) Immune Globulin treatment prevents sensitization that can lead to Rh disease, but does not prevent or treat the ... According to immune network theory, the adaptive immune system is regulated by interactions between idiotypes. The Fc region ( ... Chemical similarities to polypetide chains of myeloma globulins and normal gamma-globulins". The Journal of Experimental ...
Evidence to support Rho(D) immune globulin after a spontaneous miscarriage is unclear. In the UK, Rho(D) immune globulin is ... Women who have a blood type of rhesus negative (Rh negative) may require Rho(D) immune globulin. Pain medication may be ... A disruption in normal immune function can lead to the formation of antiphospholipid antibody syndrome. This will affect the ... Preventing a miscarriage in subsequent pregnancies may be enhanced with assessments of: Immune status Chemical and occupational ...
... immune globulin to administer. In this test, a sample of maternal blood is incubated with Rho(D) immune globulin, which will ... This estimate, in turn, also estimates the required amount of Rho(D) ...
In 1968, Ortho introduced RhoGAM Rho(D) immune globulin, the first medication developed to prevent Rh hemolytic disease of the ...
In 1964, Ortho Pharmaceutical asked Peeters to participate in a clinical trial of a variant of RhoGAM, its Rho(D) immune ... globulin. He accepted. Peeters took the lead of a small team of doctors and a great number of midwives, whom he alerted to the ...
Rh disease can be prevented by administration of anti-D IgG (Rho(D) Immune Globulin) injections to RhD-negative mothers during ... This anemia can have either an immune or non-immune cause. Non-immune hydrops can also be unrelated to anemia, for example if a ... Immune Globulin).[citation needed] Severe anemia leads to hyperdynamic circulation, which means high-output cardiac failure ... In the event of a pregnancy where the fetus has the Rh-D blood antigen and the mother does not, the mother's immune system will ...
... developed the Rho(D) immune globulin vaccine for Rh disease, complications from diabetes and heart disease. Reshma, c. 66, ...
The vast majority of Rh disease is preventable in modern antenatal care by injections of IgG anti-D antibodies (Rho(D) Immune ... and positive reaction at anti-human globulin (AHG) phase. Weak D phenotype can occur in several ways. In some cases, this ... Landsteiner K, Wiener AS (1940). "An Agglutinable Factor in Human Blood Recognized by Immune Sera for Rhesus Blood". Exp Biol ... Rho(D) meaning RhD positive). Wiener's notation is more complex and cumbersome for routine use. Because it is simpler to ...
... immune globulin. With successful mitigation of this disease by prevention through the use of anti-Rho(D) immune globulin, other ... In an RhD negative mother, Rho(D) immune globulin can prevent temporary sensitization of the maternal immune system to RhD ... Marianne Cummins was the first at risk woman to receive a prophylactic injection of anti-Rho(D) immune globulin (RHIG) after ... Pollack's direction confirmed that anti-Rho(D) immune globulin could prevent alloimmunization during pregnancy.[citation needed ...
Rho(D) immune globulin). ECV has existed since 384-322 B.C., the time of Aristotle. Around 100 A.D., Soranus of Ephesus ...
... and because Rh-negative mothers who have developed an anti-RhD antibody are not eligible to receive Rho(D) immune globulin ( ... thus avoiding unnecessary treatment with Rho(D) immune globulin. Genotyping is preferred to serologic testing for people with ... The anti-human globulin could bind to antibodies already attached to red blood cells and cause them to agglutinate. The ... If IgG antibodies have bound to antigens on the cell surface, anti-human globulin will bind to those antibodies, causing the ...
Rho(D) Immune Globulin) are used to prevent Rh disease, but the methods for IgG anti-Kell 1 antibodies have not been developed ... "Plasmapheresis and intravenous immune globulin for the treatment of D alloimmunization in pregnancy". Journal of Clinical ... "Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization". ... "Acute hemolytic transfusion reactions may be either immune-mediated or nonimmune-mediated. Immune-mediated hemolytic ...
... in the form of Rho(D) immune globulin, as treatment. Since its discovery, Gorman's treatment is estimated to have saved ...
... rho(d) immune globulin MeSH D12.776.377.715.548.114.619.574 - immunoglobulin m MeSH D12.776.377.715.548.114.619.574.500 - ... sex hormone-binding globulin MeSH D12.776.377.715.182.839 - transferrin MeSH D12.776.377.715.548.114 - antibodies MeSH D12.776. ... gamma-globulins MeSH D12.776.377.715.548.397.500 - tuftsin MeSH D12.776.377.715.548.538 - immunoglobulin constant regions MeSH ... immune sera MeSH D12.776.377.715.548.114.573.203 - antilymphocyte serum MeSH D12.776.377.715.548.114.580 - immunoconjugates ...
Rhesus-negative mothers who are pregnant with a rhesus-positive infant are offered Rho(D) immune globulin (RhIG, or RhoGam) at ... Novak DJ, Tyler LN, Reddy RL, Barsoom MJ (2008). "Plasmapheresis and intravenous immune globulin for the treatment of D ... Since the introduction of Rho-D immunoglobulin, (Rhogam, at 1968, which prevents the production of maternal Rho-D antibodies, ... "Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization". ...
... rho(d) immune globulin MeSH D12.776.124.486.485.114.619.574 - immunoglobulin m MeSH D12.776.124.486.485.114.619.574.500 - ... rho(d) immune globulin MeSH D12.776.124.790.651.114.619.574 - immunoglobulin m MeSH D12.776.124.790.651.114.619.574.500 - ... immune sera MeSH D12.776.124.486.485.114.573.203 - antilymphocyte serum MeSH D12.776.124.486.485.114.573.601 - antitoxins MeSH ... gamma-globulins MeSH D12.776.124.486.485.397.500 - tuftsin MeSH D12.776.124.486.485.538 - immunoglobulin constant regions MeSH ...
... immune globulin (anti-D immunoglobulin) Anti-rabies immunoglobulin Anti-tetanus immunoglobulin Normal immunoglobulinα ... α Protamine sulfateα Warfarinα Deferoxamineα Hydroxycarbamideα Fresh frozen plasma Platelets Red blood cells Whole blood Rho(D ...
also recommended are Rho(D) immune globulin in those who are rh negative, corticosteroids in those who are 24 to 34 weeks and ...
" "Inner Uterus Blood Transfusions" - 1960s Rhesus blood group system Rh disease Rho(D) Immune Globulin St. Louis Post Dispatch ... a condition which would cause pregnant women's immune system to attack the fetus she is carrying as not being identical to the ...
Rho(D) immune globulin or splenectomy. Romiplostim treatment is generally administered at weekly intervals via subcutaneous ... February 2008). "Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised ... Romiplostim is indicated as a potential treatment for chronic idiopathic (immune) thrombocytopenic purpura (ITP). Romiplostim ... thus overwhelming the immune system's ability to destroy them. As doing so involves changes to the bone marrow chemistry, a ...
Rho(D) immune globulin) are used to prevent Rh disease, but the methods for IgG anti-Rhc antibodies have not been developed at ... "Plasmapheresis and intravenous immune globulin for the treatment of D alloimmunization in pregnancy". Journal of Clinical ... "Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization". ... "Acute hemolytic transfusion reactions may be either immune-mediated or nonimmune-mediated. Immune-mediated hemolytic ...
... immune globulin Secretion assay Self-protein Sensitization (immunology) Sentinel cell Serum amyloid A Short course immune ... Reproductive immunology Respiratory burst Respiratory tract antimicrobial defense system Restriction modification system Rho(D ... IL22RA2 Immune adherence Immune complex Immune dysregulation Immune network theory Immune privilege Immune receptor Immune ... Immunology is the study of the immune system during health and disease. Below is a list of immunology-related articles. ...
... immune globulin. Antibodies associated with some blood groups can cause severe HDN, others can only cause mild HDN and others ... this disease by stopping the formation of Anti-D antibodies by D negative mothers with an injectable medication called Rho(D) ... The most significant Rh antigen is the D antigen, because it is the most likely to provoke an immune system response of the ... if they can bind to the corresponding antibodies to generate an immune response. Transfusions are further complicated because ...
It is usually performed on Rh-negative mothers to determine the required dose of Rho(D) immune globulin (RhIg) to inhibit ... An estimate of the required number of Rho(D) immune globulin vials may assume the following equations: Volume (mL) of Fetal ...
... (February 26, 1926 - November 3, 2013) was a British-born American immunologist who developed the Rho(D) immune ... globulin vaccine against Rh disease, a leading cause of erythroblastosis fetalis. Pollack co-developed the vaccine, also known ...
Immune Globulin Intravenous (IGIV) Octapharma Pharmazeutika, Vienna, Austria: Immune Globulin Intravenous (IGIV) Sangachal ... Rho(D) IGIV Genzyme Ireland Ltd. (filling), Waterford, Ireland: Thymoglobulin Glaxo Smith Kline SpA (fill/finish), Parma, Italy ... Immune Globulin Intravenous (IGIV) Maghreb-Europe (GME) gas pipeline, Algeria Recip AB Sweden: Thyrosafe (potassium iodine) ... Immune Globulin Intravenous (IGIV) Metal Fabrication Machines: Small number of Turkish companies (Durma, Baykal, Ermaksan) ...
Supportive care includes prophylactic antimicrobials, and consideration of immune globulin replacement. Interferon alpha has ... Meller N, Merlot S, Guda C (2005). "CZH proteins: a new family of Rho-GEFs". J. Cell Sci. 118 (Pt 21): 4937-46. doi:10.1242/jcs ... Dock8 was identified during a yeast two hybrid (YTH) screen for proteins that interact with the Rho family small G protein ... "Scientists Identify Genetic Cause of Previously Undefined Primary Immune Deficiency Disease". National Institutes of Health ( ...
SLC6A20 Immune dysfunction with T-cell inactivation due to calcium entry defect 1; 612782; ORAI1 Immune dysfunction, with T- ... RHO Nijmegen breakage syndrome; 251260; NBS1 Nijmegen breakage syndrome-like disorder; 613078; RAD50 Nonaka myopathy; 605820; ... CNTNAP2 Corticosteroid-binding globulin deficiency; 611489; CBG Cortisone reductase deficiency; 604931; H6PD Cortisone ... PIK3CA Combined cellular and humoral immune defects with granulomas; 233650; RAG1 Combined cellular and humoral immune defects ...
... immune cell - immune system - immunoglobulin - immunoglobulin joining region - immunoglobulin variable region - immunologic ... alpha-globulin - alpha-macroglobulin - alpha-MSH - Ames test - amide - amine - amino - amino acid - amino acid receptor - amino ... rho factor - rhodopsin - ribonucleoprotein - ribose - ribosomal protein - ribosomal protein S6 kinase - ribosome - RNA - RNA ...
Rho and Ras small GTPases are involved in the principal leukocyte signaling pathways underlying chemokine-stimulated integrin- ... Pathway building has been performed by individual groups studying a network of interest (e.g., immune signaling pathway) as ... globulin protease inhibitors, complement, coagulation and fibrinolytic systems and iron homeostasis Regulate iron homeostasis ( ... For actin polymerization through the cadherin pathway, proteins of the Rho GTPases family are also involved. This complex is ...
Lack of Transmission of Human Immunodeficiency Virus Through Rho(D) Immune Globulin (Human) On September 18, 1987, the Armed ... Several epidemiologic and laboratory studies have shown that recipients of hepatitis B immune globulin (HBIG) and immune ... Rho(D) Immune Globulin (human) (Rh-IG), manufactured by Ortho Diagnostic Systems, Inc. This action was taken because a woman on ... Safety of therapeutic immune globulin preparations with respect to transmission of human T-lymphotropic (sic) virus type III/ ...
HUMAN RHO(D) IMMUNE GLOBULIN (UNII: 48W7181FLP) (HUMAN RHO(D) IMMUNE GLOBULIN - UNII:48W7181FLP) HUMAN RHO(D) IMMUNE GLOBULIN. ... immune globulin, human 1500 UNT in 2 ML Prefilled Syringe. PSN. 2. 1117759. 2 ML Rho(D) immune globulin, human 750 UNT/ML ... RHOPHYLAC (human rho- d immune globulin solution. To receive this label RSS feed. Copy the URL below and paste it into your RSS ... RHOPHYLAC (human rho- d immune globulin solution. If this SPL contains inactivated NDCs listed by the FDA initiated compliance ...
Immune Globulin (Human)) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related ... rho(d) immune globulin (human)) , MICRhoGAM (rho(d) immune globulin (human)) or any other Rho(D) Immune Globulin (Human). ... RhoGAM (rho(d) immune globulin (human)) and MICRhoGAM (rho(d) immune globulin (human)) act by suppressing the immune response ... RhoGAM (rho(d) immune globulin (human)) and MICRhoGAM (rho(d) immune globulin (human)) are made from human plasma. Because ...
Breastfeeding/Statistics and Research ... Breastfeeding ... National Library of Medicine ... From the National Institutes of Health ... The LactMed® database contains information ...
... immune globulin (human). et al. JAMA. (1987) Lack of transmission of human immunodeficiency virus through Rho(D) immune ... Misleading hepatitis B serology following Rho (D) immune globulin (human) injection and influenza vaccine. Chen X et al. Clin ... "immune"[All Fields] AND "globulin"[All Fields]) OR "immune globulin"[All Fields]). Search. ... "humans"[MeSH Terms] OR "humans"[All Fields] OR "human"[All Fields]) AND RHO[All Fields]) AND D[All Fields] AND (" ...
... immune globulin is an immune globulin rich in IgG antibodies against erythrocyte antigen Rho(D). IgG is a normal component of ... Rho(D) immune globulin is an immune globulin rich in IgG antibodies against erythrocyte antigen Rho(D). IgG is a normal ... Rho(D) Immune Globulin No authors listed In: Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National ... Rho(D) immune globulin is frequently used in nursing mothers and no adverse effects have been reported in breastfed infants. No ...
... immune globulin is an immune globulin rich in IgG antibodies against erythrocyte antigen Rho(D). IgG is a normal component of ... Rho(D) immune globulin is an immune globulin rich in IgG antibodies against erythrocyte antigen Rho(D). IgG is a normal ... Rho(D) Immune Globulin No authors listed In: Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National ... Rho(D) immune globulin is frequently used in nursing mothers and no adverse effects have been reported in breastfed infants. No ...
HUMAN RHO(D) IMMUNE GLOBULIN (UNII: 48W7181FLP) (HUMAN RHO(D) IMMUNE GLOBULIN - UNII:48W7181FLP) HUMAN RHO(D) IMMUNE GLOBULIN. ... HUMAN RHO(D) IMMUNE GLOBULIN (UNII: 48W7181FLP) (HUMAN RHO(D) IMMUNE GLOBULIN - UNII:48W7181FLP) HUMAN RHO(D) IMMUNE GLOBULIN. ... HUMAN RHO(D) IMMUNE GLOBULIN (UNII: 48W7181FLP) (HUMAN RHO(D) IMMUNE GLOBULIN - UNII:48W7181FLP) HUMAN RHO(D) IMMUNE GLOBULIN. ... HUMAN RHO(D) IMMUNE GLOBULIN (UNII: 48W7181FLP) (HUMAN RHO(D) IMMUNE GLOBULIN - UNII:48W7181FLP) HUMAN RHO(D) IMMUNE GLOBULIN. ...
Rho immune globulin (WinRho). *Ribavirin. *Snake bites (some snake venom contains hemolytic toxins) ...
If your baby is Rh negative, no treatment is required.) Trusted SourceMayo Clinic Rho(D) Immune Globulin (Injection Route, ... Mayo Clinic, Rho(D) Immune Globulin (Injection Route, Intramuscular Route, Intravenous Route), November 2022. , Show in the ... Mayo Clinic, Rho(D) Immune Globulin (Injection Route, Intramuscular Route, Intravenous Route), February 2021. *National Center ... If youre Rh negative at 28 weeks, youll get an injection of Rho(D) immune globulin (RhoGAM) to prevent antibodies from ...
Rho (D) immune globulin,RhoGAM,128,1,r,1, Rimactane,rifampin,128,1,r,1, Rimactane,Rifadin,128,1,r,1, Romilar,dextromethorphan ... tetanus immune human globulin,128,1,r,1, Homo-Tet,Hu-Tet,128,1,r,1, Homo-Tet,Hyper-Tet,128,1,r,1, hospital,nosocomial,1,1,r,1, ... pertussis immune human globulin,Hypertussis,128,1,r,1, phagocytolytic,phagolytic,1,1,r,1, Phe-Mer-Nite,phenylmercuric nitrate, ... immune globulin,128,1,r,1, immunosuppressive,immunosuppressant,128,1,r,1, immunosuppressive,immunosuppressiveness,128,1,r,1, ...
Dermatofibrosarcoma protuberans arising at a Rho(D) immune globulin injection site.. Hirano SA; Torosky CM. Cutis; 2012 Nov; 90 ...
Immune Globulin, Rh MICRhoGAM Rh Immune Globulin Rho(D) Immune Globulin Intravenous (Human) Rho(D) Immune Human Globulin RhoGAM ... Rho(D) Immune Globulin Intravenous (Human) Narrower Concept UI. M0462971. Registry Number. 0. Terms. Rho(D) Immune Globulin ... Rh Immune Globulin Broader Concept UI. M000638650. Registry Number. 0. Terms. Rh Immune Globulin Preferred Term Term UI T053910 ... Gamma Globulins (1978-1983). Immunoglobulins (1973-1993). Public MeSH Note. 1994; RHO(D) IMMUNE GLOBULIN was indexed under ...
RhoGAM Rho(D) Immune Globulin (Human) is a sterile solution containing IgG anti-D (RH1) for use in preventing Rh immunization. ... Immune Globulin (Human) must contain at least as much anti-D as 1 milliliter of the U.S. Reference Rho (D) Immune Globulin ( ... A full dose of Rh o (D) Immune Globulin (Human) has traditionally been referred to as a 300 g dose and this usage is employed ... It is also not known whether Rh o (D) Immune Globulin (Human) can cause fetal harm when administered to a pregnant woman or can ...
Rho(D) Immune Globulin,N0000006217, magaldrate,N0000006218, dalfopristin,N0000006219, Testolactone,N0000006220, sorbitan ... Globulins,N0000007615, Interferon Type I,N0000007614, Epoxy Compounds,N0000007613, Interferon Type I, Recombinant,N0000007612, ... Alpha-Globulins,N0000007645, Nipecotic Acids,N0000007644, Acrylic Resins,N0000007643, Lactams,N0000007642, Nicotinic Acids, ... Serum Globulins,N0000008244, Growth Substances, Pigments, and Vitamins,N0000008243, Pregnanes,N0000008242, Androstanes, ...
... immune globulin; specific immune globulins; and immune globulin, intravenous {IGIV}) can diminish the immune response to MMR or ... the postpartum vaccination of rubella-susceptible women with the rubella or MMR vaccine should not be delayed because anti-Rho( ... such as serum immune globulin, specific immune globulins {e.g., TIG and HBIG}, intravenous immune globulin {IGIV}, whole blood ... Recent Injection of Immune Globulin The effect of immune globulin preparations on the response to mumps vaccine is unknown, but ...
Globulin, Rh Immune. Immune Globulin, Rh. MICRhoGAM. Rh Immune Globulin. Rho(D) Immune Globulin Intravenous (Human). Rho(D) ... Rho(D) Immune Globulin Intravenous (Human) - Narrower Concept UI. M0462971. Preferred term. Rho(D) Immune Globulin Intravenous ... Rho(D) Immune Globulin - Preferred Concept UI. M0027215. Scope note. Immunizing agent containing IMMUNOGLOBULIN G anti-Rho(D) ... Gamma Globulins (1978-1983). Immunoglobulins (1973-1993). Public MeSH Note:. 1994; RHO(D) IMMUNE GLOBULIN was indexed under ...
Immune Globulin, Rh MICRhoGAM Rh Immune Globulin Rho(D) Immune Globulin Intravenous (Human) Rho(D) Immune Human Globulin RhoGAM ... Rho(D) Immune Globulin Intravenous (Human) Narrower Concept UI. M0462971. Registry Number. 0. Terms. Rho(D) Immune Globulin ... Rh Immune Globulin Broader Concept UI. M000638650. Registry Number. 0. Terms. Rh Immune Globulin Preferred Term Term UI T053910 ... Gamma Globulins (1978-1983). Immunoglobulins (1973-1993). Public MeSH Note. 1994; RHO(D) IMMUNE GLOBULIN was indexed under ...
Teste Pré-Natal não Invasivo/economia; Isoimunização Rh/prevenção & controle; Imunoglobulina rho(D)/uso terapêutico; Ácidos ... To compare the efficacy and costs of three different strategies of antenatal rhesus immune globulin (RhIG) administration in a ... Cell free fetal DNA to triage antenatal rhesus immune globulin: Is it really cost-effective in the United States? ... Cell free fetal DNA to triage antenatal rhesus immune globulin: Is it really cost-effectiv ...
Rho (D) immune globulin, E0069846,Antiminth,pyrantel pamoate, E0069852,Eskalith,lithium carbonate, E0069863,Sublimaze,fentanyl ... immune globulin intravenous, E0692561,Carimune NF,immune globulin intravenous, E0692562,Blephamide,medicated eye solutions, ... RhO(D) immune serum globulin, E0070996,Ketaset,ketamine hydrochloride, E0070997,Adrucil,fluorouracil, E0070998,Uticillin, ... Rho (D) immune globulin, E0415015,Risperidal,risperidone, E0415017,Salflex,salicylsalicylic acid, E0415020,Vagistat,tioconazole ...
Rho (D) immune globulin,RhoGAM,128,1,r,1, Rimactane,rifampin,128,1,r,1, Rimactane,Rifadin,128,1,r,1, Romilar,dextromethorphan ... tetanus immune human globulin,128,1,r,1, Homo-Tet,Hu-Tet,128,1,r,1, Homo-Tet,Hyper-Tet,128,1,r,1, hospital,nosocomial,1,1,r,1, ... pertussis immune human globulin,Hypertussis,128,1,r,1, phagocytolytic,phagolytic,1,1,r,1, Phe-Mer-Nite,phenylmercuric nitrate, ... immune globulin,128,1,r,1, immunosuppressive,immunosuppressant,128,1,r,1, immunosuppressive,immunosuppressiveness,128,1,r,1, ...
The shot is called Rho(D) immune globulin .. An ultrasound test checks how many weeks pregnant you are. ...
0.17 ML Rho(D) Immune Globulin 0.3 MG/ML Prefilled Syringe. 0.17 ML Rho(D) Immune Globulin 0.3 MG/ML Prefilled Syringe. RxNorm ...
Rho(d) immune globulin or cyclosporine are pre- ferred compared with radiation therapy. Is it acute or chronic urinary ...
Gamulin Rh use Rho(D) Immune Globulin Gamunex use Immunoglobulins, Intravenous Gan cao use Glycyrrhiza uralensis ...
... had no known significant mercury exposure except from Thimerosal-containing vaccines/Rho(D)-immune globulin preparations; and ( ... immune globulin preparations. Based upon differential diagnoses, 8 of 9 patients examined were exposed to significant mercury ... The suboptimal immune response caused by original antigenic sin is observed when the host is exposed to an antigen which has ... Immune memory normally allows for an improved and rapid response to antigens previously seen and is the mechanism by which ...
A Prospective Study of Thimerosal-Containing Rho(D)-Immune Globulin Administration as a Risk Factor for Autistic Disorders ...
rho(d) immune globulin (human). Injection. 103777. 1998-04-23. ⤷ Try a Trial. ...
HyperRAB S/D - Rabies immune globulin (By injection). *HyperRHO S/D - Rho(d) immune globulin (By injection) ... HyperHEP B - Hepatitis B immune globulin (By injection). *Hyperlite - Parenteral electrolyte/mineral combination (By injection) ... Hizentra - Immune globulin subcutaneous (By injection). *Hizentra - Immune globulin (By injection). [top]. Ho. *Homatropaire - ... HepaGam B - Hepatitis B immune globulin (By injection). *HepaGam B Novaplus - Hepatitis B immune globulin (By injection) ...
  • The base line serum concentrations of luteinizing hormone, follicle stimulating hormone, and sex hormone-binding globulin were similar in the four groups, and the concentrations decreased significantly in the two testosterone groups. (agapegym.org)
  • This study consisted of a longitudinal look at how adult exposure to the water pollutant TCE altered the immune system of female MRL+/+ mice. (biomedfrontiers.org)
  • Essential Role of Rho-Associated Kinase in ABO Immune Complex-Mediated Endothelial Barrier Disruption. (rochester.edu)
  • 1 step only- Skin test used to determine if someone has developed an immune response to the bacterium that causes TB. (ohtestingusa.com)
  • This was calculated without considering intra patient correlation IPC correlation rho ρ between baseline and follow up and without potential intra cluster correlation ICC of patients treated by the same physician. (agapegym.org)
  • Intravascular hemolysis leading to death has been reported in Rh (D)-positive patients treated for immune thrombocytopenic purpura (ITP) with Rh(D) Immune Globulin Intravenous (Human) products. (nih.gov)
  • Intravenous immune globulin (IGIV): A product derived from blood plasma from a donor pool similar to the IG pool, but prepared so it is suitable for intravenous use. (cdc.gov)
  • For a list of intravenous immune globulins, see Table_2 . (cdc.gov)
  • Specific immune globulin: Special preparations obtained from blood plasma from donor pools preselected for a high antibody content against a specific antigen (e.g., hepatitis B immune globulin, varicella-zoster immune globulin, rabies immune globulin, tetanus immune globulin, vaccinia immune globulin, and cytomegalovirus immune globulin). (cdc.gov)
  • In a clinical study in eight healthy human adults receiving another hyperimmune immune globulin product treated with solvent/detergent, Rabies Immune Globulin (Human), Hyper RAB ® S/D, prepared by the same manufacturing process, detectable passive antibody titers were observed in the serum of all subjects by 24 hours post injection and persisted through the 21 day study period. (nih.gov)
  • Rho(D) immune globulin is an immune globulin rich in IgG antibodies against erythrocyte antigen Rho(D). IgG is a normal component of breastmilk. (nih.gov)
  • Immune globulin (IG): A sterile solution containing antibodies from human blood. (cdc.gov)
  • Hyper RHO S/D Full Dose is prepared by cold ethanol fractionation from human plasma. (nih.gov)
  • Similarly, immunization resulting in the production of anti-Rh o (D) following transfusion of Rh positive red cells to an Rh o (D) negative recipient may be prevented by administering Rh o (D) Immune Globulin (Human). (nih.gov)
  • 10 ) Bowman and Pollock( 11 ) have reported that the incidence of isoimmunization can be further reduced from approximately 1.6% to less than 0.1% by administering Rh o (D) Immune Globulin (Human) in two doses, one antenatal at 28 weeks' gestation and another following delivery. (nih.gov)
  • DEFINITIONS Immunobiologic: Immunobiologics include antigenic substances, such as vaccines and toxoids, or antibody-containing preparations, such as globulins and antitoxins, from human or animal donors. (cdc.gov)
  • Three types of immunobiologics are administered for passive immunization: a) pooled human IG or IGIV, b) specific immune globulin preparations, and c) antitoxins. (cdc.gov)
  • It is primarily used for replacement therapy in primary antibody-deficiency disorders, for the treatment of Kawasaki disease, immune thrombocytopenic purpura, hypogammaglobulinemia in chronic lymphocytic leukemia, and some cases of HIV infection. (cdc.gov)
  • Rho(D) immune globulin is frequently used in nursing mothers and no adverse effects have been reported in breastfed infants. (nih.gov)
  • Active immunization is the production of antibody or other immune responses through the administration of a vaccine or toxoid. (cdc.gov)
  • Immunizing agent containing IMMUNOGLOBULIN G anti-Rho(D) used for preventing Rh immunization in Rh-negative individuals exposed to Rh-positive red blood cells. (nih.gov)
  • Hyper RHO S/D Full Dose is formulated as a 15-18% protein solution at a pH of 6.4-7.2 in 0.21-0.32 M glycine. (nih.gov)
  • Hyper RHO S/D Full Dose is then incubated in the final container for 21-28 days at 20-27°C. (nih.gov)
  • The removal and inactivation of spiked model enveloped and non-enveloped viruses during the manufacturing process for Hyper RHO S/D Full Dose has been validated in laboratory studies. (nih.gov)
  • Hyper RHO S/D Full Dose is used to prevent isoimmunization in the Rh o (D) negative individual exposed to Rh o (D) positive blood as a result of a fetomaternal hemorrhage occurring during a delivery of an Rh o (D) positive infant, abortion (either spontaneous or induced), or following amniocentesis or abdominal trauma. (nih.gov)
  • 7,8 ) Hyper RHO S/D Full Dose acts by suppressing the immune response of Rh o (D) negative individuals to Rh o (D) positive red blood cells. (nih.gov)
  • The mechanism of action of Hyper RHO S/D Full Dose is not fully understood. (nih.gov)
  • List four adverse reactions which have been associated with the administration of Rho(D) Immune Globulin (RhIg). (nih.gov)

No images available that match "rho d immune globulin"